<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="mcleod" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">mcleod</book-part-id>
      <title-group>
        <title>McLeod Neuroacanthocytosis Syndrome</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Jung</surname>
            <given-names>Hans H</given-names>
          </name>
          <degrees>MD</degrees>
          <email>Hans.Jung@usz.ch</email>
          <aff>Department of Neurology<break/>University Hospital Zurich<break/>Zurich, Switzerland</aff>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Danek</surname>
            <given-names>Adrian</given-names>
          </name>
          <degrees>MD</degrees>
          <email>danek@lmu.de</email>
          <aff>Neurologische Klinik <break/>Ludwig-Maximilians-Universit&#x000e4;t<break/>M&#x000fc;nchen, Germany</aff>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Walker</surname>
            <given-names>Ruth H</given-names>
          </name>
          <degrees>MD, MBBS, PhD</degrees>
          <email>ruth.walker@mssm.edu</email>
          <aff>Department of Neurology<break/>Veterans Affairs Medical Center<break/>Bronx, New York</aff>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Frey</surname>
            <given-names>Beat M</given-names>
          </name>
          <degrees>MD</degrees>
          <email>bm.frey@zhbsd.ch</email>
          <aff>Blood Transfusion Service<break/>Swiss Red Cross<break/>Schlieren/Z&#x000fc;rich, Switzerland</aff>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Gassner</surname>
            <given-names>Christoph</given-names>
          </name>
          <degrees>PhD</degrees>
          <email>c.gassner@zhbsd.ch</email>
          <aff>Blood Transfusion Service<break/>Swiss Red Cross<break/>Schlieren/Z&#x000fc;rich, Switzerland</aff>
        </contrib>
      </contrib-group>
      <pub-history>
        <date iso-8601-date="2004-12-03" date-type="created">
          <day>3</day>
          <month>12</month>
          <year>2004</year>
        </date>
        <date iso-8601-date="2012-05-17" date-type="updated">
          <day>17</day>
          <month>5</month>
          <year>2012</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="mkks" document-type="chapter">McKusick-Kaufman Syndrome</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="mcad" document-type="chapter">Medium-Chain Acyl-Coenzyme A Dehydrogenase Deficiency</related-object>
      <abstract id="mcleod.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>McLeod neuroacanthocytosis syndrome (designated as MLS throughout this review) is a multisystem disorder with central nervous system (CNS), neuromuscular, and hematologic manifestations in males. CNS manifestations are a neurodegenerative basal ganglia disease including (1) movement disorders, (2) cognitive alterations, and (3) psychiatric symptoms. Neuromuscular manifestations include a (mostly subclinical) sensorimotor axonopathy and muscle weakness or atrophy of different degrees. Hematologically, MLS is defined as a specific blood group phenotype (named after the first proband, Hugh McLeod) that results from absent expression of the Kx erythrocyte antigen and weakened expression of Kell blood group antigens. The hematologic manifestations are red blood cell acanthocytosis and compensated hemolysis. Allo-antibodies in the Kell and Kx blood group system can cause strong reactions to transfusions of incompatible blood and severe anemia in newborns of Kell-negative mothers. Females heterozygous for <italic toggle="yes">XK</italic> pathogenic variants have mosaicism for the Kell and Kx blood group antigens but usually lack CNS and neuromuscular manifestations; however, some heterozygous females may develop clinical manifestations including chorea or late-onset cognitive decline.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The diagnosis of MLS is based on findings on clinical examination, immunohematologic testing, and flow cytometry. <italic toggle="yes">XK</italic> is the only gene in which pathogenic variants are known to cause MLS. Contiguous gene deletions involving <italic toggle="yes">XK</italic> may also include <italic toggle="yes">CYBB</italic> (causing X-linked chronic granulomatous disease); <italic toggle="yes">DMD</italic> (Duchenne muscular dystrophy); and <italic toggle="yes">RPGR</italic> (X-linked retinitis pigmentosa).</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations</italic>: Dopamine antagonists (e.g., tiapride, clozapine, quetiapine) and the dopamine depletory (tetrabenazine) may be used to ameliorate chorea; treatment of psychiatric problems, cardiac abnormalities, and seizures are based on the clinical findings; long-term and continuous multidisciplinary psychosocial support is needed for affected individuals and their families.</p>
          <p><italic toggle="yes">Prevention of secondary complications</italic>: Kx-negative blood or banked autologous blood for transfusions when possible.</p>
          <p><italic toggle="yes">Surveillance</italic>: Holter ECG and echocardiography every two to three years in those without known cardiac complications; consider placement of prophylactic cardiac pacemaker; monitor for seizures; monitor serum CK concentrations for evidence of rhabdomyolysis if excessive movement disorders are present or if neuroleptic medications are being used.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>MLS is inherited in an X-linked manner. If the mother of an affected male is a carrier, the chance of transmitting the <italic toggle="yes">XK</italic> pathogenic variant in each pregnancy is 50%. Males who inherit the variant will be affected; females who inherit the variant will be carriers and will usually not be affected. Affected males pass the pathogenic variant to all of their daughters and none of their sons. Prenatal testing for pregnancies at increased risk is possible through laboratories offering either testing for the gene of interest or custom testing.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="mcleod.Diagnosis">
        <title>Diagnosis</title>
        <sec id="mcleod.Clinical_Diagnosis">
          <title>Clinical Diagnosis</title>
          <p>Diagnosis of McLeod neuroacanthocytosis syndrome (MLS) is established in individuals with the following combination of manifestations:</p>
          <list list-type="bullet">
            <list-item>
              <p>The McLeod blood group phenotype</p>
            </list-item>
            <list-item>
              <p>A family history consistent with X-linked inheritance AND any combination of the following:</p>
              <list list-type="bullet">
                <list-item>
                  <p>CNS manifestations</p>
                  <list list-type="bullet">
                    <list-item>
                      <p>Progressive chorea syndrome similar to that seen in Huntington disease including the clinical triad of movement disorder, cognitive alterations, and psychiatric symptoms</p>
                    </list-item>
                    <list-item>
                      <p>Seizures, mostly generalized</p>
                    </list-item>
                  </list>
                </list-item>
                <list-item>
                  <p>Neuromuscular manifestations (often subclinical or mild)</p>
                  <list list-type="bullet">
                    <list-item>
                      <p>Sensorimotor axonopathy</p>
                    </list-item>
                    <list-item>
                      <p>Neurogenic muscle atrophy</p>
                    </list-item>
                    <list-item>
                      <p>Myopathy</p>
                    </list-item>
                  </list>
                </list-item>
                <list-item>
                  <p>Dilated cardiomyopathy and arrhythmias</p>
                </list-item>
              </list>
            </list-item>
          </list>
        </sec>
        <sec id="mcleod.Testing">
          <title>Testing</title>
          <sec id="mcleod.Hematologic_Testing">
            <title>Hematologic Testing</title>
            <p>
              <bold>McLeod blood group phenotype</bold>
            </p>
            <list list-type="bullet">
              <list-item>
                <p>In affected males the diagnosis of the McLeod blood group phenotype is based on the immunohematologic determination of absent expression of the Kx erythrocyte antigen and reduced expression of the Kell blood group antigens using human anti-Kx and monoclonal anti-Kell antibodies, respectively [<xref ref-type="bibr" rid="mcleod.REF.allen.1961.555">Allen et al 1961</xref>, <xref ref-type="bibr" rid="mcleod.REF.lee.2000b.113">Lee et al 2000b</xref>, <xref ref-type="bibr" rid="mcleod.REF.jung.2007.112">Jung et al 2007</xref>]. Serologically weakened or absent Kell antigens, along with documented presence of <italic toggle="yes">KEL</italic> and related genes in genomic DNA and in conjunction with serologically absent Kx erythrocyte antigen, is pathognomonic for the McLeod blood group phenotype.</p>
              </list-item>
              <list-item>
                <p>McLeod blood group phenotype is established by showing negativity for Kx erythrocyte antigen and weakened or absent expression of at least two to three antithetic pairs of Kell antigens (Kell/Cellano, Kpa/b, Jsa/b), thus differentiating the phenotype from individuals with <italic toggle="yes">KEL</italic>-null (K<sub>0</sub>) phenotype, which is characterized by strong expression of Kx. Expression of Kx / Kell protein complex on red blood cell membrane can also be evaluated by flow cytometry.</p>
              </list-item>
              <list-item>
                <p>In heterozygous females mixed red blood cell populations may be identified with flow cytometric analysis of Kx and Kell RBC antigens on red blood cell membrane [<xref ref-type="bibr" rid="mcleod.REF.oyen.1996.160">Oyen et al 1996</xref>, <xref ref-type="bibr" rid="mcleod.REF.kawakami.1999.36">Kawakami et al 1999</xref>, <xref ref-type="bibr" rid="mcleod.REF.jung.2001a.384">Jung et al 2001a</xref>, <xref ref-type="bibr" rid="mcleod.REF.singleton.2003.682">Singleton et al 2003</xref>, <xref ref-type="bibr" rid="mcleod.REF.jung.2007.112">Jung et al 2007</xref>].</p>
              </list-item>
            </list>
          </sec>
          <sec id="mcleod.Red_Blood_Cell_Studies">
            <title>Red Blood Cell Studies</title>
            <p><bold>RBC acanthocytosis</bold> is found in virtually all males with MLS; repeat testing may be required. Note: No data regarding the age at which acanthocytosis develops are available.</p>
            <p>Accurate determination of RBC acanthocytosis is challenging. The best procedure requires diluting whole blood samples 1:1 with heparinized saline followed by incubation for 60 minutes at room temperature; wet cell monolayers are then prepared for phase-contrast microscopy. When all RBCs with spicules (corresponding to type AI/AII acanthocytes and echinocytes) are counted, normal controls show less than 6.3% acanthocytes/echinocytes [<xref ref-type="bibr" rid="mcleod.REF.storch.2005.84">Storch et al 2005</xref>]. Acanthocyte count in MLS may vary considerably but usually ranges between 8% and 30%.</p>
            <p>Confirmation of erythrocyte morphology by scanning electron microscopy (if available) may be helpful.</p>
            <p><bold>Compensated hemolysis</bold> (i.e., hemolysis without anemia) is found in virtually all males with MLS. The following can be used to evaluate for hemolysis:</p>
            <list list-type="bullet">
              <list-item>
                <p>Assessment for allo-antibodies against high frequency antigens (anti-public antibodies) such as anti-Kx, anti-K20, and anti-Km antibodies</p>
              </list-item>
              <list-item>
                <p>Exclusion of autoimmune hemolytic anemia by negative direct antiglobulin test (DAT)</p>
              </list-item>
              <list-item>
                <p>Investigation for biochemical markers of hemolysis (LDH, haptoglobin, bilirubin, reticulocytes) and muscle disorder (CPK, CPK-MB)</p>
              </list-item>
            </list>
          </sec>
          <sec id="mcleod.Neuromuscular_and_Cardiac_Studies">
            <title>Neuromuscular and Cardiac Studies</title>
            <p><bold>Muscle enzymes.</bold> All males with MLS examined to date have had elevated serum creatine phosphokinase (CK) concentrations reaching values up to 4000 U/L [<xref ref-type="bibr" rid="mcleod.REF.danek.2001a.755">Danek et al 2001a</xref>, <xref ref-type="bibr" rid="mcleod.REF.jung.2001a.384">Jung et al 2001a</xref>].</p>
            <p>Serum concentrations of LDH, AST, and ALT may also be elevated [<xref ref-type="bibr" rid="mcleod.REF.danek.2001a.755">Danek et al 2001a</xref>, <xref ref-type="bibr" rid="mcleod.REF.jung.2001a.384">Jung et al 2001a</xref>].</p>
            <p>
              <bold>Clinical electroneuromyography</bold>
            </p>
            <list list-type="bullet">
              <list-item>
                <p>Electromyography may demonstrate neurogenic and myopathic changes [<xref ref-type="bibr" rid="mcleod.REF.danek.2001a.755">Danek et al 2001a</xref>].</p>
              </list-item>
              <list-item>
                <p>Electroneurography may demonstrate axonal damage of variable degree [<xref ref-type="bibr" rid="mcleod.REF.danek.2001a.755">Danek et al 2001a</xref>].</p>
              </list-item>
            </list>
            <p><bold>Muscle CT.</bold> Computed tomography (CT) scan of muscle may reveal a selective pattern of fatty degeneration of lower-leg muscles preferentially affecting the vastus lateralis, biceps femoris, and adductor magnus muscles, and sparing the gracilis, semitendinosus, and lateral head of the gastrocnemius muscle [<xref ref-type="bibr" rid="mcleod.REF.ishikawa.2000.1113">Ishikawa et al 2000</xref>].</p>
            <p><bold>Muscle biopsy</bold> shows myopathic as well as neurogenic alterations, which were predominant in most studies:</p>
            <list list-type="bullet">
              <list-item>
                <p>Several studies demonstrated fiber type grouping, type 1 fiber predominance, type 2 fiber atrophy, increased variability in fiber size, and increased central nucleation [<xref ref-type="bibr" rid="mcleod.REF.swash.1983.717">Swash et al 1983</xref>, <xref ref-type="bibr" rid="mcleod.REF.jung.2001b.1346">Jung et al 2001b</xref>].</p>
              </list-item>
              <list-item>
                <p>In a series of ten individuals with MLS, including the original index patient, all had abnormal muscle histology: four had clear but nonspecific myopathic changes; however, all had neurogenic changes of variable degree consistent with predominant neurogenic muscle atrophy [<xref ref-type="bibr" rid="mcleod.REF.hewer.2007.3285">Hewer et al 2007</xref>].</p>
              </list-item>
              <list-item>
                <p>One individual with an <italic toggle="yes">XK</italic> pathogenic missense variant had normal histologic and immunohistochemical findings [<xref ref-type="bibr" rid="mcleod.REF.jung.2003.928">Jung et al 2003</xref>].</p>
              </list-item>
              <list-item>
                <p>In muscle of healthy individuals, Kell antigen was located in the sarcoplasmic membranes and Kx immunohistochemistry revealed a type 2 fiber-specific intracellular staining most probably confined to the sarcoplasmic reticulum. Muscle in males with MLS revealed no expression of Kx or Kell [<xref ref-type="bibr" rid="mcleod.REF.jung.2001b.1346">Jung et al 2001b</xref>].</p>
              </list-item>
            </list>
            <p><bold>Nerve histology</bold>. Nerve biopsy may demonstrate a chronic axonal neuropathy with prominent regenerative activity and selective loss of large myelinated fibers [<xref ref-type="bibr" rid="mcleod.REF.dotti.2004">Dotti et al 2004</xref>].</p>
            <p>Post-mortem motor and sensory nerve examinations demonstrated axonal motor neuropathy [<xref ref-type="bibr" rid="mcleod.REF.hewer.2007.3285">Hewer et al 2007</xref>].</p>
            <p>
              <bold>Cardiac studies</bold>
            </p>
            <list list-type="bullet">
              <list-item>
                <p>Echocardiography may demonstrate congestive cardiomyopathy or dilated cardiomyopathy [<xref ref-type="bibr" rid="mcleod.REF.mohiddin.2004">Mohiddin &#x00026; Fananapazzir 2004</xref>].</p>
              </list-item>
              <list-item>
                <p>Electrocardiography (ECG) may demonstrate atrial fibrillation or tachyarrhythmia [<xref ref-type="bibr" rid="mcleod.REF.mohiddin.2004">Mohiddin &#x00026; Fananapazzir 2004</xref>].</p>
              </list-item>
              <list-item>
                <p>In seven males with MLS, one presented with a cardiomyopathy and died from sudden cardiac death in the absence of any cardiovascular risk factors. Autopsy demonstrated eccentric hypertrophy and mild left ventricular dilatation. Histopathology was not specific and revealed focal myocyte hypertrophy, slight variation of myofiber size, and patchy interstitial fibrosis [<xref ref-type="bibr" rid="mcleod.REF.witt.1992.302">Witt et al 1992</xref>, <xref ref-type="bibr" rid="mcleod.REF.oechslin.2009.130">Oechslin et al 2009</xref>].</p>
              </list-item>
            </list>
          </sec>
          <sec id="mcleod.Central_Nervous_System_Studies">
            <title>Central Nervous System Studies</title>
            <p>
              <bold>Neuroimaging</bold>
            </p>
            <list list-type="bullet">
              <list-item>
                <p>In asymptomatic heterozygous females and early in the disease course in affected males, neuroimaging findings may be normal [<xref ref-type="bibr" rid="mcleod.REF.jung.2001a.384">Jung et al 2001a</xref>, <xref ref-type="bibr" rid="mcleod.REF.jung.2003.928">Jung et al 2003</xref>].</p>
              </list-item>
              <list-item>
                <p>In affected males, CT and magnetic resonance imaging (MRI) of the brain may demonstrate atrophy of the caudate nucleus and putamen of variable degree [<xref ref-type="bibr" rid="mcleod.REF.danek.2001a.755">Danek et al 2001a</xref>, <xref ref-type="bibr" rid="mcleod.REF.jung.2001a.384">Jung et al 2001a</xref>]. Basal ganglia volumes are inversely correlated with disease duration [<xref ref-type="bibr" rid="mcleod.REF.jung.2001a.384">Jung et al 2001a</xref>]. A follow-up study of three individuals with MLS over seven years using an automated subcortical segmentation procedure demonstrated decreasing caudate volumes [<xref ref-type="bibr" rid="mcleod.REF.valko.2010.612">Valko et al 2010</xref>].</p>
              </list-item>
              <list-item>
                <p>In two males with MLS, cerebral MRI demonstrated extended T<sub>2</sub>-hyperintense white matter alterations [<xref ref-type="bibr" rid="mcleod.REF.danek.2001a.755">Danek et al 2001a</xref>, <xref ref-type="bibr" rid="mcleod.REF.nicholl.2004.1200">Nicholl et al 2004</xref>].</p>
              </list-item>
            </list>
            <p><bold>Magnetic resonance spectroscopy (MRS).</bold>
<sup>1</sup>H-MRS demonstrates pathologic NAA/(Cr+Cho) ratios in frontal, temporal, and insular areas with an individual pattern in males with MLS who have predominant psychiatric or neuropsychological manifestations [<xref ref-type="bibr" rid="mcleod.REF.dydak.2006.17">Dydak et al 2006</xref>].</p>
            <p><bold>Nuclear medicine.</bold> SPECT studies using <sup>123</sup>I-IMP and <sup>123</sup>I-IBZM, respectively, revealed reduction of striatal perfusion as well as striatal D2-receptor density in some males with MLS [<xref ref-type="bibr" rid="mcleod.REF.danek.1994.117">Danek et al 1994</xref>, <xref ref-type="bibr" rid="mcleod.REF.oechsner.2001.517">Oechsner et al 2001</xref>].</p>
            <p>Using [<sup>18</sup>F]-FDG (2-fluoro-2-deoxy-glucose) PET, bilaterally reduced striatal glucose uptake was found in all symptomatic individuals with MLS [<xref ref-type="bibr" rid="mcleod.REF.jung.2001a.384">Jung et al 2001a</xref>, <xref ref-type="bibr" rid="mcleod.REF.oechsner.2001.517">Oechsner et al 2001</xref>]. Quantitative FDG-PET also demonstrated reduced striatal glucose uptake in asymptomatic males with the McLeod blood group phenotype and in female heterozygotes [<xref ref-type="bibr" rid="mcleod.REF.jung.2001a.384">Jung et al 2001a</xref>, <xref ref-type="bibr" rid="mcleod.REF.oechsner.2001.517">Oechsner et al 2001</xref>]. The degree of reduction of striatal glucose uptake also correlated with disease duration [<xref ref-type="bibr" rid="mcleod.REF.jung.2001a.384">Jung et al 2001a</xref>].</p>
            <p><bold>Brain pathology.</bold> Data from four individuals with MLS (3 males and 1 manifesting female carrier) are available [<xref ref-type="bibr" rid="mcleod.REF.hardie.1991.13">Hardie et al 1991</xref>, <xref ref-type="bibr" rid="mcleod.REF.danek.2008">Danek et al 2008</xref>, <xref ref-type="bibr" rid="mcleod.REF.geser.2008">Geser et al 2008</xref>]:</p>
            <list list-type="bullet">
              <list-item>
                <p>In the manifesting female carrier, marked striatal atrophy was noted, corresponding to nonspecific loss of nerve cells and reactive astrocytic gliosis with predominant alterations in the head of the caudate nucleus [<xref ref-type="bibr" rid="mcleod.REF.hardie.1991.13">Hardie et al 1991</xref>].</p>
              </list-item>
              <list-item>
                <p>In two males similar alterations were found with severe atrophy of the striatum and (less pronounced) of the globus pallidus [<xref ref-type="bibr" rid="mcleod.REF.danek.2008">Danek et al 2008</xref>, <xref ref-type="bibr" rid="mcleod.REF.geser.2008">Geser et al 2008</xref>]. Marked neuronal loss and astrocytic gliosis were observed on histologic examination. Moderate focal subcortical and subtle cortical astrocytic gliosis, particularly in frontal areas, was noted.</p>
              </list-item>
              <list-item>
                <p>In contrast to <related-object link-type="booklink" source-id="gene" document-id="chac" document-type="chapter">chorea-acanthocytosis</related-object> (ChAc), none of the four individuals with MLS demonstrated pathology in the thalamus or substantia nigra. Neither Lewy bodies nor definite abnormalities in other brain areas (e.g., the cortex) were observed.</p>
              </list-item>
            </list>
          </sec>
          <sec id="mcleod.Molecular_Genetic_Testing">
            <title>Molecular Genetic Testing</title>
            <p><bold>Gene.</bold>
<italic toggle="yes">XK</italic> is the only gene in which pathogenic variants are known to cause MLS.</p>
            <p><bold>Research.</bold> In males with an intragenic <italic toggle="yes">XK</italic> deletion, the X-chromosomal breakpoints can be located and characterized by DNA sequencing. To identify and determine the extent of a contiguous gene deletion, a chromosomal microarray analysis may be performed.</p>
            <table-wrap id="mcleod.T.summary_of_molecular_genetic_te" position="anchor" orientation="portrait">
              <label>Table 1. </label>
              <caption>
                <p>Summary of Molecular Genetic Testing Used in McLeod Neuroacanthocytosis Syndrome</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_mcleod.T.summary_of_molecular_genetic_te_1_1_1_1" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_mcleod.T.summary_of_molecular_genetic_te_1_1_1_1">Gene&#x000a0;<sup>1</sup></th>
                    <th id="hd_h_mcleod.T.summary_of_molecular_genetic_te_1_1_1_2" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_mcleod.T.summary_of_molecular_genetic_te_1_1_1_2">Test Method</th>
                    <th id="hd_h_mcleod.T.summary_of_molecular_genetic_te_1_1_1_3" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_mcleod.T.summary_of_molecular_genetic_te_1_1_1_3">Pathogenic Variants Detected&#x000a0;<sup>2</sup></th>
                    <th id="hd_h_mcleod.T.summary_of_molecular_genetic_te_1_1_1_4" valign="middle" colspan="2" align="left" scope="colgroup" rowspan="1">Variant Detection Frequency by Test Method&#x000a0;<sup>3</sup></th>
                  </tr>
                  <tr>
                    <th headers="hd_h_mcleod.T.summary_of_molecular_genetic_te_1_1_1_4" id="hd_h_mcleod.T.summary_of_molecular_genetic_te_1_1_2_1" valign="middle" colspan="1" align="left" scope="colgroup" rowspan="1">Affected Males</th>
                    <th headers="hd_h_mcleod.T.summary_of_molecular_genetic_te_1_1_1_4" id="hd_h_mcleod.T.summary_of_molecular_genetic_te_1_1_2_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Carrier Females</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_mcleod.T.summary_of_molecular_genetic_te_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                      <italic toggle="yes">XK</italic>
                    </td>
                    <td headers="hd_h_mcleod.T.summary_of_molecular_genetic_te_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>4</sup></td>
                    <td headers="hd_h_mcleod.T.summary_of_molecular_genetic_te_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sequence variants&#x000a0;<sup>5</sup></td>
                    <td headers="hd_h_mcleod.T.summary_of_molecular_genetic_te_1_1_1_4 hd_h_mcleod.T.summary_of_molecular_genetic_te_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Probably &#x0003e;95%&#x000a0;<sup>4,&#x000a0;5</sup></td>
                    <td headers="hd_h_mcleod.T.summary_of_molecular_genetic_te_1_1_1_4 hd_h_mcleod.T.summary_of_molecular_genetic_te_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Probably &#x0003e;95%&#x000a0;<sup>6</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_mcleod.T.summary_of_molecular_genetic_te_1_1_1_2" valign="top" colspan="1" align="left" scope="row" rowspan="1">Deletion/duplication analysis&#x000a0;<sup>7</sup></td>
                    <td headers="hd_h_mcleod.T.summary_of_molecular_genetic_te_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Exon and whole-gene deletion/duplication</td>
                    <td headers="hd_h_mcleod.T.summary_of_molecular_genetic_te_1_1_1_4 hd_h_mcleod.T.summary_of_molecular_genetic_te_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Probably &#x0003e;95%</td>
                    <td headers="hd_h_mcleod.T.summary_of_molecular_genetic_te_1_1_1_4 hd_h_mcleod.T.summary_of_molecular_genetic_te_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Probably &#x0003e;95%</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn id="mcleod.TF.1.1">
                  <label>1. </label>
                  <p>See <related-object source-id="gene" document-id="mcleod" object-id="mcleod.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
                </fn>
                <fn id="mcleod.TF.1.2">
                  <label>2. </label>
                  <p>See <xref ref-type="sec" rid="mcleod.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants.</p>
                </fn>
                <fn id="mcleod.TF.1.3">
                  <label>3. </label>
                  <p>The ability of the test method used to detect a variant that is present in the indicated gene</p>
                </fn>
                <fn id="mcleod.TF.1.4">
                  <label>4. </label>
                  <p>Examples of pathogenic variants detected by sequence analysis may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
                </fn>
                <fn id="mcleod.TF.1.5">
                  <label>5. </label>
                  <p>Lack of amplification by PCR prior to sequence analysis can suggest a putative deletion of one or more exons or the whole gene on the X chromosome in affected males; confirmation may require additional testing by deletion/duplication analysis.</p>
                </fn>
                <fn id="mcleod.TF.1.6">
                  <label>6. </label>
                  <p>Sequence analysis of genomic DNA cannot detect deletion of one or more exons or the entire X-linked gene in a heterozygous female.</p>
                </fn>
                <fn id="mcleod.TF.1.7">
                  <label>7. </label>
                  <p>Testing that identifies deletions/duplications not readily detectable by sequence analysis of the coding and flanking intronic regions of genomic DNA; included in the variety of methods that may be used are: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and chromosomal microarray (CMA) that includes this gene/chromosome segment.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <p>An overview of all currently known <italic toggle="yes">XK</italic> pathogenic variants, including large X-chromosomal deletions is available at the <bold>Blood Group Antigen Gene Mutation Database</bold> (dbRBC); see <related-object source-id="gene" document-id="mcleod" object-id="mcleod.molgen.TA">Table A</related-object>.</p>
          </sec>
        </sec>
        <sec id="mcleod.Testing_Strategy">
          <title>Testing Strategy</title>
          <p><bold>To establish the diagnosis of MLS in a male proband</bold> with a Huntington disease-like disorder and elevated CK levels:</p>
          <list list-type="bullet">
            <list-item>
              <p>Establish McLeod blood group phenotype by immunohematologic methods. Note: The presence of the McLeod blood group phenotype establishes the diagnosis of MLS.</p>
            </list-item>
            <list-item>
              <p>Quantify acanthocytes in freshly prepared wet blood smear using phase-contrast microscopy (supportive of the diagnosis but not mandatory).</p>
            </list-item>
          </list>
          <p><bold>To confirm the diagnosis of MLS in a male proband</bold>, use molecular genetic testing to identify a pathogenic <italic toggle="yes">XK</italic> variant.</p>
          <p><bold>Contiguous gene rearrangements.</bold> Large deletions involving multiple genes at Xp21.1 may cause other disorders in individuals with MLS (see <xref ref-type="sec" rid="mcleod.Contiguous_Gene_Rearrangements">Contiguous Gene Rearrangements</xref>). To determine the genes involved in a contiguous gene deletion, chromosomal microarray analysis can be performed</p>
          <p><bold>Carrier testing for at-risk female relatives</bold> requires one of the following: (a) flow cytometric analysis of Kx and Kell erythrocyte antigens; (b) prior identification of the pathogenic variant in the family; or (c) if an affected male is not available for testing, molecular genetic testing first by sequence analysis, and then, if no pathogenic variant is identified, by deletion/duplication analysis.</p>
          <p>Note: Heterozygous females may develop clinical manifestations such as chorea or late-onset cognitive decline.</p>
          <p><bold>Predictive testing</bold> for at-risk asymptomatic adult family members requires determination of the McLeod blood group phenotype in at-risk males, flow cytometric analysis of Kx and Kell RBC antigens in at-risk heterozygote females, and/or prior identification of the pathogenic variant in the family.</p>
          <p><bold>Genotype-phenotype correlations</bold>. Molecular characterization of individual genetic defect may give evidence of clinical disease manifestation: to date, three <italic toggle="yes">XK</italic> pathogenic missense variants that may result in a milder phenotype have been described [<xref ref-type="bibr" rid="mcleod.REF.russo.2002.287">Russo et al 2002</xref>, <xref ref-type="bibr" rid="mcleod.REF.jung.2003.928">Jung et al 2003</xref>, <xref ref-type="bibr" rid="mcleod.REF.walker.2007a.299">Walker et al 2007a</xref>] (see <xref ref-type="table" rid="mcleod.T.selected_xk_pathogenic_variants">Table 4</xref>).</p>
          <p><bold>Prenatal diagnosis and preimplantation genetic diagnosis (PGD)</bold> for at-risk pregnancies require prior identification of the pathogenic variants in the family.</p>
        </sec>
        <sec id="mcleod.Contiguous_Gene_Rearrangements">
          <title>Contiguous Gene Rearrangements</title>
          <p>Other genes that lie in close proximity to <italic toggle="yes">XK</italic> at Xp21.1 include the following [<xref ref-type="bibr" rid="mcleod.REF.peng.2007.142">Peng et al 2007</xref>]:</p>
          <list list-type="bullet">
            <list-item>
              <p><italic toggle="yes">CYBB</italic> encoding the cytoplasmic subunit of phagocyte NADPH oxidase (phox) protein termed gp91<sup>phox</sup></p>
            </list-item>
            <list-item>
              <p><italic toggle="yes">RPGR</italic> encoding retinitis pigmentosa GTPase regulator</p>
            </list-item>
            <list-item>
              <p><italic toggle="yes">OTC</italic> encoding ornithine transcarbamylase</p>
            </list-item>
            <list-item>
              <p><italic toggle="yes">DMD</italic> encoding the protein dystrophin</p>
            </list-item>
          </list>
          <p>Large deletions in Xp21.1 can therefore cause the following disorders in individuals with MLS. Note: Concurrent deletion of <italic toggle="yes">CYBB</italic> with <italic toggle="yes">XK</italic> is the most common; deletion of all five genes is exceedingly rare.</p>
          <list list-type="bullet">
            <list-item>
              <p>X-linked <related-object link-type="booklink" source-id="gene" document-id="cgd" document-type="chapter">chronic granulomatous disease</related-object> (X-linked CGD) (deletion of <italic toggle="yes">CYBB</italic>) is a primary immunodeficiency disorder of phagocytes (neutrophils, monocytes, macrophages, and eosinophils). Impaired killing of bacteria and fungi result in severe recurrent bacterial and fungal infections and dysregulated inflammatory response that causes granuloma formation and other inflammatory disorders such as colitis.</p>
            </list-item>
            <list-item>
              <p><italic toggle="yes">RPGR</italic>-related <related-object link-type="booklink" source-id="gene" document-id="rp-overview" document-type="chapter">retinitis pigmentosa</related-object> (<italic toggle="yes">RPGR</italic>; previously <italic toggle="yes">RP3</italic>)</p>
            </list-item>
            <list-item>
              <p><related-object link-type="booklink" source-id="gene" document-id="otc-def" document-type="chapter">Ornithine transcarbamylase deficiency</related-object> (<italic toggle="yes">OTC</italic>) leading to <related-object link-type="booklink" source-id="gene" document-id="ucd-overview" document-type="chapter">urea cycle defects</related-object></p>
            </list-item>
            <list-item>
              <p><related-object link-type="booklink" source-id="gene" document-id="dbmd" document-type="chapter">Duchenne muscular dystrophy</related-object> (<italic toggle="yes">DMD</italic>)</p>
            </list-item>
          </list>
        </sec>
      </sec>
      <sec id="mcleod.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="mcleod.Clinical_Description">
          <title>Clinical Description</title>
          <p>McLeod neuroacanthocytosis syndrome (MLS) is a multisystem disorder with central nervous system (CNS), neuromuscular, and hematologic manifestations in males. CNS manifestations of MLS resemble <related-object link-type="booklink" source-id="gene" document-id="huntington" document-type="chapter">Huntington disease</related-object>. Symptoms comprise the prototypic triad of a progressive neurodegenerative basal ganglia disease including (1) movement disorder, (2) cognitive alterations, and (3) psychiatric symptoms [<xref ref-type="bibr" rid="mcleod.REF.danek.2001a.755">Danek et al 2001a</xref>, <xref ref-type="bibr" rid="mcleod.REF.jung.2007.112">Jung et al 2007</xref>]. It should be noted that each sign and symptom may develop in isolation or in variable combinations.</p>
          <p>Choreiform movements are the presenting symptom in about 30% of individuals with MLS, and develop in up to 95% of individuals over time [<xref ref-type="bibr" rid="mcleod.REF.danek.2001b.882">Danek et al 2001b</xref>, <xref ref-type="bibr" rid="mcleod.REF.jung.2001a.384">Jung et al 2001a</xref>, <xref ref-type="bibr" rid="mcleod.REF.hewer.2007.3285">Hewer et al 2007</xref>]. Some individuals with MLS develop head drops, feeding dystonia, and gait abnormalities, symptoms formerly believed to be specific to another type of neuroacanthocytosis, the autosomal recessive <related-object link-type="booklink" source-id="gene" document-id="chac" document-type="chapter">chorea-acanthocytosis</related-object> [<xref ref-type="bibr" rid="mcleod.REF.chauveau.2011.1562">Chauveau et al 2011</xref>, <xref ref-type="bibr" rid="mcleod.REF.gantenbein.2011.2123">Gantenbein et al 2011</xref>].</p>
          <p>Cognitive alterations are not a major presenting symptom of MLS; however, frontal-type cognitive deficits are eventually found in at least 50% of individuals during the course of the disease [<xref ref-type="bibr" rid="mcleod.REF.danek.2001a.755">Danek et al 2001a</xref>, <xref ref-type="bibr" rid="mcleod.REF.jung.2001a.384">Jung et al 2001a</xref>, <xref ref-type="bibr" rid="mcleod.REF.danek.2004">Danek et al 2004</xref>, <xref ref-type="bibr" rid="mcleod.REF.hewer.2007.3285">Hewer et al 2007</xref>].</p>
          <p>About 20% of individuals manifest psychiatric abnormalities including personality disorder, anxiety, depression, obsessive-compulsive disorder, bipolar disorder, or schizo-affective disorder. Psychopathology develops in about 80% of individuals over time [<xref ref-type="bibr" rid="mcleod.REF.danek.2001a.755">Danek et al 2001a</xref>, <xref ref-type="bibr" rid="mcleod.REF.jung.2001a.384">Jung et al 2001a</xref>, <xref ref-type="bibr" rid="mcleod.REF.jung.2004.722">Jung &#x00026; Haker 2004</xref>, <xref ref-type="bibr" rid="mcleod.REF.walterfang.2011.1275">Walterfang et al 2011</xref>].</p>
          <p>Seizures are the presenting symptom in about 20% of individuals. Up to 40% of individuals with MLS eventually have seizures, usually described as generalized seizures.</p>
          <p>Neuromuscular manifestations are not a common presenting symptom of MLS. However, almost all individuals with MLS have absent deep tendon reflexes as an indication of a (mostly subclinical) sensorimotor axonopathy [<xref ref-type="bibr" rid="mcleod.REF.danek.2001a.755">Danek et al 2001a</xref>, <xref ref-type="bibr" rid="mcleod.REF.jung.2001a.384">Jung et al 2001a</xref>]. About 50% of individuals develop clinically relevant muscle weakness or atrophy of a neurogenic nature during the disease course. Deterioration rate is slow, and few individuals develop severe weakness [<xref ref-type="bibr" rid="mcleod.REF.kawakami.1999.36">Kawakami et al 1999</xref>, <xref ref-type="bibr" rid="mcleod.REF.danek.2001a.755">Danek et al 2001a</xref>, <xref ref-type="bibr" rid="mcleod.REF.jung.2001a.384">Jung et al 2001a</xref>, <xref ref-type="bibr" rid="mcleod.REF.hewer.2007.3285">Hewer et al 2007</xref>].</p>
          <p>Cardiac manifestations including dilated cardiomyopathy, atrial fibrillation, and tachyarrhythmia are rarely presenting signs and symptoms of MLS. About 60% of individuals develop cardiac manifestations over time [<xref ref-type="bibr" rid="mcleod.REF.witt.1992.302">Witt et al 1992</xref>, <xref ref-type="bibr" rid="mcleod.REF.danek.2001a.755">Danek et al 2001a</xref>, <xref ref-type="bibr" rid="mcleod.REF.oechslin.2009.130">Oechslin et al 2009</xref>].</p>
          <p>Hepatosplenomegaly, most probably resulting from compensated hemolysis, occurs in about one third of males with MLS [<xref ref-type="bibr" rid="mcleod.REF.danek.2001a.755">Danek et al 2001a</xref>].</p>
          <p>About 30% of males with the McLeod blood group phenotype do not have neuromuscular or CNS symptoms at the time of initial diagnosis of the blood group abnormalities and are only recognized during routine work up in blood banks or in the course of family evaluations [<xref ref-type="bibr" rid="mcleod.REF.danek.2001a.755">Danek et al 2001a</xref>, <xref ref-type="bibr" rid="mcleod.REF.jung.2001a.384">Jung et al 2001a</xref>, <xref ref-type="bibr" rid="mcleod.REF.jung.2007.112">Jung et al 2007</xref>]. However, most males with the McLeod blood group phenotype developed neurologic manifestations during long-term follow-up [<xref ref-type="bibr" rid="mcleod.REF.danek.2001a.755">Danek et al 2001a</xref>, <xref ref-type="bibr" rid="mcleod.REF.hewer.2007.3285">Hewer et al 2007</xref>].</p>
          <p>The age of onset of neurologic manifestations ranges from 18 to 61 years; the majority of individuals become symptomatic before age 40 years. Almost all clinical observations indicate a slowly progressive disease course [<xref ref-type="bibr" rid="mcleod.REF.danek.2001a.755">Danek et al 2001a</xref>, <xref ref-type="bibr" rid="mcleod.REF.jung.2001a.384">Jung et al 2001a</xref>, <xref ref-type="bibr" rid="mcleod.REF.valko.2010.612">Valko et al 2010</xref>]. Because of difficulty in determining the exact onset of disease, few reliable data regarding disease duration are available. Activities of daily living may become impaired as a result of the movement disorder, psychiatric symptoms, intellectual disability, and/or cardiomyopathy.</p>
          <p>The interval between reported disease onset and death ranges from seven to 51 years [<xref ref-type="bibr" rid="mcleod.REF.danek.2001a.755">Danek et al 2001a</xref>, <xref ref-type="bibr" rid="mcleod.REF.jung.2001a.384">Jung et al 2001a</xref>, <xref ref-type="bibr" rid="mcleod.REF.hewer.2007.3285">Hewer et al 2007</xref>]. Mean age of death is 53 years, ranging from 31 to 69 years [<xref ref-type="bibr" rid="mcleod.REF.danek.2001a.755">Danek et al 2001a</xref>, <xref ref-type="bibr" rid="mcleod.REF.jung.2001a.384">Jung et al 2001a</xref>, <xref ref-type="bibr" rid="mcleod.REF.hewer.2007.3285">Hewer et al 2007</xref>]. Cardiac problems, in particular tachyarrhythmia, appear to be a major cause of premature death in MLS. Cardiovascular events, epileptic seizures, and aspiration pneumonia may be the major causes of death in older individuals [<xref ref-type="bibr" rid="mcleod.REF.danek.2001a.755">Danek et al 2001a</xref>, <xref ref-type="bibr" rid="mcleod.REF.jung.2001a.384">Jung et al 2001a</xref>, <xref ref-type="bibr" rid="mcleod.REF.hewer.2007.3285">Hewer et al 2007</xref>].</p>
          <p><bold>Females</bold> who are heterozygous for an <italic toggle="yes">XK</italic> pathogenic variant have mosaicism for the Kell system blood group and RBC acanthocytosis by virtue of X-chromosome inactivation [<xref ref-type="bibr" rid="mcleod.REF.oyen.1996.160">Oyen et al 1996</xref>, <xref ref-type="bibr" rid="mcleod.REF.kawakami.1999.36">Kawakami et al 1999</xref>, <xref ref-type="bibr" rid="mcleod.REF.jung.2001a.384">Jung et al 2001a</xref>, <xref ref-type="bibr" rid="mcleod.REF.singleton.2003.682">Singleton et al 2003</xref>, <xref ref-type="bibr" rid="mcleod.REF.jung.2007.112">Jung et al 2007</xref>]. Some heterozygous females may develop clinical manifestations such as chorea or late-onset cognitive decline.</p>
          <p>The most probable reason for the following clinical manifestations observed in female heterozygotes is skewed X-chromosome inactivation, in which the X chromosome with the normal <italic toggle="yes">XK</italic> allele is by chance inactivated in a disproportionately large number of cells [<xref ref-type="bibr" rid="mcleod.REF.ho.1996.672">Ho et al 1996</xref>]. Pertinent observations are:</p>
          <list list-type="bullet">
            <list-item>
              <p>One female heterozygote developed the typical MLS phenotype [<xref ref-type="bibr" rid="mcleod.REF.hardie.1991.13">Hardie et al 1991</xref>].</p>
            </list-item>
            <list-item>
              <p>A female heterozygote had acanthocytosis, a bimodal pattern of Kell blood group antigens on flow cytometry, elevated serum creatine kinase concentrations, and a tic-like movement disorder [<xref ref-type="bibr" rid="mcleod.REF.kawakami.1999.36">Kawakami et al 1999</xref>].</p>
            </list-item>
            <list-item>
              <p>In one family, female heterozygotes had slight cognitive deficits and reduced striatal glucose uptake in the absence of an obvious movement disorder [<xref ref-type="bibr" rid="mcleod.REF.jung.2001a.384">Jung et al 2001a</xref>].</p>
            </list-item>
          </list>
        </sec>
        <sec id="mcleod.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>Data presently available are insufficient to draw conclusions about genotype-phenotype correlations in McLeod neuroacanthocytosis syndrome [<xref ref-type="bibr" rid="mcleod.REF.danek.2001a.755">Danek et al 2001a</xref>]. MLS shows considerable phenotypic variability, even between family members with identical <italic toggle="yes">XK</italic> variants [<xref ref-type="bibr" rid="mcleod.REF.danek.2001b.882">Danek et al 2001b</xref>, <xref ref-type="bibr" rid="mcleod.REF.walker.2007b.244">Walker et al 2007b</xref>].</p>
          <p>Only three pathogenic <italic toggle="yes">XK</italic> missense variants have been reported so far. Although rare, they are potentially useful in the elucidation of structural and functional relationships. See <xref ref-type="sec" rid="mcleod.Molecular_Genetics">Molecular Genetics</xref>.</p>
          <list list-type="bullet">
            <list-item>
              <p>The <xref ref-type="table" rid="mcleod.T.selected_xk_pathogenic_variants">c.979G&#x0003e;A</xref> variant was associated with an isolated immunohematologic phenotype without evidence for muscular, central, and peripheral nervous system involvement [<xref ref-type="bibr" rid="mcleod.REF.jung.2003.928">Jung et al 2003</xref>].</p>
            </list-item>
            <list-item>
              <p>Similarly, an individual with the <xref ref-type="table" rid="mcleod.T.selected_xk_pathogenic_variants">c.664C&#x0003e;G</xref> variant did not show significant neurologic or systemic abnormalities [<xref ref-type="bibr" rid="mcleod.REF.walker.2007a.299">Walker et al 2007a</xref>].</p>
            </list-item>
            <list-item>
              <p>Also, a single base substitution in an intron near a splice junction (<xref ref-type="table" rid="mcleod.T.selected_xk_pathogenic_variants">c.508+5G&#x0003e;A</xref>, resulting in alternative splicing and some degree of normal splicing) did not lead to any significant neurologic abnormalities [<xref ref-type="bibr" rid="mcleod.REF.walker.2007a.299">Walker et al 2007a</xref>].</p>
            </list-item>
            <list-item>
              <p>In contrast, an individual with the <xref ref-type="table" rid="mcleod.T.selected_xk_pathogenic_variants">c.880T&#x0003e;C</xref> variant manifested the full McLeod neuroacanthocytosis syndrome [<xref ref-type="bibr" rid="mcleod.REF.danek.2001a.755">Danek et al 2001a</xref>].</p>
            </list-item>
          </list>
        </sec>
        <sec id="mcleod.Penetrance">
          <title>Penetrance</title>
          <p>In males, the penetrance of neurologic and neuromuscular manifestations of MLS is high after age 50 years, perhaps even complete. Available data indicate that most males with the "McLeod blood group phenotype" will develop clinical symptoms of McLeod neuroacanthocytosis syndrome [<xref ref-type="bibr" rid="mcleod.REF.bertelson.1988.703">Bertelson et al 1988</xref>, <xref ref-type="bibr" rid="mcleod.REF.hardie.1991.13">Hardie et al 1991</xref>, <xref ref-type="bibr" rid="mcleod.REF.danek.2001a.755">Danek et al 2001a</xref>, <xref ref-type="bibr" rid="mcleod.REF.jung.2001b.1346">Jung et al 2001b</xref>]. In a few individuals, however, neurologic and neuromuscular symptoms may be absent or only minor even after long-term follow up [<xref ref-type="bibr" rid="mcleod.REF.jung.2003.928">Jung et al 2003</xref>, <xref ref-type="bibr" rid="mcleod.REF.walker.2007a.299">Walker et al 2007a</xref>].</p>
          <p>In the past, many reports (including that of the index case) described only hematologic findings, and no neurologic or neuroimaging work up was performed in these individuals [<xref ref-type="bibr" rid="mcleod.REF.allen.1961.555">Allen et al 1961</xref>, <xref ref-type="bibr" rid="mcleod.REF.symmans.1979.575">Symmans et al 1979</xref>, <xref ref-type="bibr" rid="mcleod.REF.bertelson.1988.703">Bertelson et al 1988</xref>, <xref ref-type="bibr" rid="mcleod.REF.lee.2000a.93">Lee et al 2000a</xref>]. In many of these individuals neurologic manifestations were noted during long-term follow-up [<xref ref-type="bibr" rid="mcleod.REF.bertelson.1988.703">Bertelson et al 1988</xref>, <xref ref-type="bibr" rid="mcleod.REF.danek.2001a.755">Danek et al 2001a</xref>].</p>
        </sec>
        <sec id="mcleod.Nomenclature">
          <title>Nomenclature</title>
          <p>The term "neuroacanthocytosis" refers to several genetically and phenotypically distinct disorders [<xref ref-type="bibr" rid="mcleod.REF.danek.2004">Danek et al 2004</xref>, <xref ref-type="bibr" rid="mcleod.REF.danek.2005.171">Danek et al 2005</xref>]; see <xref ref-type="sec" rid="mcleod.Differential_Diagnosis">Differential Diagnosis</xref>.</p>
          <p>The term "McLeod blood group phenotype" describes the immunohematologic abnormalities consisting of absent expression of Kx RBC antigen and reduced expression of Kell RBC antigens in the index case originally described by <xref ref-type="bibr" rid="mcleod.REF.allen.1961.555">Allen et al [1961]</xref>.</p>
          <p>The terms "Kell blood group precursor" and "Kell blood group precursor substance" for the XK protein or the Kx RBC antigen, respectively, are incorrect and no longer in use.</p>
        </sec>
        <sec id="mcleod.Prevalence">
          <title>Prevalence</title>
          <p>The prevalence of MLS cannot be determined based on the data available from the approximately 150 cases known worldwide.</p>
        </sec>
      </sec>
      <sec id="mcleod.Genetically_Related_Allelic_Disor">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>No other phenotypes are known to be caused by mutation of <italic toggle="yes">XK</italic> alone.</p>
      </sec>
      <sec id="mcleod.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p><related-object link-type="booklink" source-id="gene" document-id="huntington" document-type="chapter"><bold>Hutington disease</bold></related-object>
<bold>(HD).</bold> HD is the prototypic hereditary chorea syndrome and manifests with progressive movement disorder and cognitive and psychiatric disturbances. The mean age of onset of HD ranges from 35 to 44 years, and the median survival is 15 to 18 years after onset. The symptoms of HD and MLS may appear indistinguishable. However, autosomal dominant inheritance and anticipation in HD and the presence of seizures, elevated serum CK concentrations, and myopathy in MLS may help distinguish the two conditions. Diagnosis of HD rests on the detection of an expansion of the CAG trinucleotide repeat in <italic toggle="yes">HTT</italic>.</p>
        <p><bold>Other neuroacanthocytosis syndromes.</bold> Neurologic disorders associated with RBC acanthocytosis have been summarized as neuroacanthocytosis syndromes [<xref ref-type="bibr" rid="mcleod.REF.danek.2004">Danek et al 2004</xref>, <xref ref-type="bibr" rid="mcleod.REF.danek.2005.171">Danek et al 2005</xref>, <xref ref-type="bibr" rid="mcleod.REF.jung.2011.68">Jung et al 2011</xref>].</p>
        <p>One group of neuroacanthocytosis syndromes is associated with lipid malabsorption and primarily affects the spinal cord, cerebellum, and peripheral nervous system. The neurologic findings include: (1) a progressive spinocerebellar degeneration with gait ataxia, dysmetria, and dysarthria; (2) a demyelinating sensorimotor and axonal peripheral neuropathy with hyporeflexia and diminished vibration and position sense; (3) rarely, pyramidal tract signs; and (4) rarely, cranial nerve involvement [<xref ref-type="bibr" rid="mcleod.REF.kane.1995">Kane &#x00026; Havel 1995</xref>, <xref ref-type="bibr" rid="mcleod.REF.tarugi.2011.81">Tarugi &#x00026; Averna 2011</xref>]. These disorders include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Hypobetalipoproteinemia type 1 (FHBL1)</p>
          </list-item>
          <list-item>
            <p>Hypobetalipoproteinemia type 2 (FHBL2)</p>
          </list-item>
          <list-item>
            <p>Abetalipoproteinemia (ABL, Bassen-Kornzweig disease)</p>
          </list-item>
        </list>
        <p>FHBL1, FHBL2, ABL, and MLS share the findings of acanthocytosis, dysarthria, neuropathy, and areflexia but differ in that ABL and HBL have pigmentary retinopathy and do not have basal ganglia involvement. ABL and HBL are caused by mutation of the gene encoding the microsomal triglyceride transfer protein causing vitamin E deficiency. ABL is inherited in an autosomal recessive manner. HBL has clinical manifestations in both the homozygous and heterozygous states.</p>
        <p>A second group of neuroacanthocytosis syndromes predominantly affects the central nervous system, in particular the basal ganglia, resulting in a chorea syndrome resembling Huntington disease (<xref ref-type="table" rid="mcleod.T.differential_diagnosis_of_mcleo">Table 2</xref>). These disorders include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="chac" document-type="chapter"><bold>Chorea-acanthocytosis</bold></related-object>
<bold>(ChAc)</bold> is characterized by a progressive movement disorder and an often subclinical myopathy, mental changes, and seizures. Seizures are observed in almost half of affected individuals and can be the initial manifestation. Progressive cognitive and behavioral changes resemble a frontal lobe syndrome. Myopathy results in progressive distal muscle wasting and weakness. The movement disorder is mostly chorea. In contrast to MLS, some individuals present with a Parkinsonian syndrome. In addition, dystonia is common and affects the trunk and in particular the oral region and the tongue, causing dysarthria and serious dysphagia with resultant weight loss. Habitual tongue and lip biting are characteristic. Mean age of onset is about 35 years, although ChAc can develop as early as the first decade or as late as the seventh decade. ChAc runs a chronic progressive course and may lead to major disability within a few years; life expectancy is reduced. Diagnosis of ChAc rests on the presence of typical clinical and MRI findings and molecular genetic testing if available. Testing for RBC expression of chorein, the <italic toggle="yes">VPS13A</italic> product, is a useful alternative [<xref ref-type="bibr" rid="mcleod.REF.dobsonstone.2004.299">Dobson-Stone et al 2004</xref>]. Inheritance is autosomal recessive.</p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="hd-l2" document-type="chapter"><bold>Huntington disease-like 2</bold></related-object>
<bold>(HDL2)</bold> manifests in the third to fourth decade and has a progressive course over ten to 15 years [<xref ref-type="bibr" rid="mcleod.REF.margolis.2001.373">Margolis et al 2001</xref>]. Phenotypic variation is marked. Dystonia is a frequent finding, and presentation with chorea or parkinsonism may change with evolution of the disease. With the exception of one Mexican pedigree, all affected individuals reported to date have been of African ancestry [<xref ref-type="bibr" rid="mcleod.REF.margolis.2001.373">Margolis et al 2001</xref>, <xref ref-type="bibr" rid="mcleod.REF.stevanin.2002.965">Stevanin et al 2002</xref>, <xref ref-type="bibr" rid="mcleod.REF.walker.2003.1002">Walker et al 2003</xref>]. RBC acanthocytes have been noted in only a few individuals with HDL2. Diagnosis of HDL2 rests on detection of an expansion of the CTG trinucleotide repeat in <italic toggle="yes">JPH3</italic>. Inheritance is autosomal dominant.</p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="pkan" document-type="chapter"><bold>Pantothenate kinase-associated neurodegeneration</bold></related-object>
<bold>(PKAN)</bold> (neurodegeneration with brain iron accumulation [NBIA], formerly Hallervorden-Spatz syndrome) is characterized by progressive dystonia and basal ganglia iron deposition with onset usually before age ten years. Dysarthria, rigidity, and pigmentary retinopathy are common. About 25% of individuals have an "atypical" presentation with onset after age ten years, prominent speech defects, psychiatric disturbance, and more gradual progression of disease [<xref ref-type="bibr" rid="mcleod.REF.swaiman.2001.102">Swaiman 2001</xref>, <xref ref-type="bibr" rid="mcleod.REF.zhou.2001.345">Zhou et al 2001</xref>]. Acanthocytosis is observed in at least 8% of individuals. The so-called 'eye of the tiger' sign on MRI is characteristic [<xref ref-type="bibr" rid="mcleod.REF.hayflick.2003.33">Hayflick et al 2003</xref>]. Diagnosis of PKAN rests on the presence of typical clinical and MRI findings, and molecular genetic testing of <italic toggle="yes">PANK2</italic>. Inheritance is autosomal recessive. See also <related-object link-type="booklink" source-id="gene" document-id="nbia-ov" document-type="chapter">Neurodegeneration with Brain Iron Accumulation Disorders Overview</related-object>.</p>
          </list-item>
          <list-item>
            <p><bold>HARP syndrome</bold> (<italic toggle="yes">h</italic>ypoprebetalipoproteinemia, <italic toggle="yes">a</italic>canthocytosis, <italic toggle="yes">r</italic>etinitis pigmentosa, and <italic toggle="yes">p</italic>allidal degeneration) is allelic with PKAN [<xref ref-type="bibr" rid="mcleod.REF.ching.2002.1673">Ching et al 2002</xref>, <xref ref-type="bibr" rid="mcleod.REF.houlden.2003.1423">Houlden et al 2003</xref>]. The continued use of this term is discouraged particularly since "hypoprebetalipoproteinemia" is not a meaningful entity.</p>
          </list-item>
        </list>
        <p><xref ref-type="table" rid="mcleod.T.differential_diagnosis_of_mcleo">Table 2</xref> summarizes the diseases in the differential diagnosis of MLS.</p>
        <table-wrap id="mcleod.T.differential_diagnosis_of_mcleo" position="anchor" orientation="portrait">
          <label>Table 2. </label>
          <caption>
            <p>Differential Diagnosis of McLeod Neuroacanthocytosis Syndrome</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Disease</th>
                <th id="hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene</th>
                <th id="hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Chromosomal Locus</th>
                <th id="hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Protein</th>
                <th id="hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_5" valign="middle" align="left" scope="col" rowspan="1" colspan="1">OMIM</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_1 hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_2 hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_3 hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_4 hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_5" valign="middle" colspan="5" align="left" scope="col" rowspan="1">
                  <bold>Autosomal Dominant</bold>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <related-object link-type="booklink" source-id="gene" document-id="huntington" document-type="chapter">Huntington disease</related-object>
                </td>
                <td headers="hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">HTT</italic>
                </td>
                <td headers="hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">4p16.3</td>
                <td headers="hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Huntingtin</td>
                <td headers="hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/143100">143100</ext-link>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">HDL1 (Huntington disease-like 1)</td>
                <td headers="hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">PRNP</italic>
                </td>
                <td headers="hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">20pter-p12</td>
                <td headers="hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Major prion protein</td>
                <td headers="hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/603218">603218</ext-link>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1"><related-object link-type="booklink" source-id="gene" document-id="hd-l2" document-type="chapter">HDL2</related-object> (Huntington disease-like 2)</td>
                <td headers="hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">JPH3</italic>
                </td>
                <td headers="hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">16q24.3</td>
                <td headers="hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Junctophilin-3</td>
                <td headers="hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/606438">606438</ext-link>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <related-object link-type="booklink" source-id="gene" document-id="drpla" document-type="chapter">Dentatorubral-pallidoluysian atrophy</related-object>
                </td>
                <td headers="hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">ATN1</italic>
                </td>
                <td headers="hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">12p13.31</td>
                <td headers="hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Atrophin-1</td>
                <td headers="hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/125370">125370</ext-link>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <related-object link-type="booklink" source-id="gene" document-id="neuroferritin" document-type="chapter">Neuroferritinopathy</related-object>
                </td>
                <td headers="hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">FTL</italic>
                </td>
                <td headers="hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">19q13.3-q13.4</td>
                <td headers="hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Ferritin light chain</td>
                <td headers="hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/606159">606159</ext-link>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <related-object link-type="booklink" source-id="gene" document-id="sca3" document-type="chapter">Spinocerebellar ataxia type 3</related-object>
                </td>
                <td headers="hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">ATXN3</italic>
                </td>
                <td headers="hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">14q24.3-q31</td>
                <td headers="hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Ataxin-3</td>
                <td headers="hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/109150">109150</ext-link>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <related-object link-type="booklink" source-id="gene" document-id="sca17" document-type="chapter">Spinocerebellar ataxia type 17</related-object>
                </td>
                <td headers="hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">TBP</italic>
                </td>
                <td headers="hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">6q27</td>
                <td headers="hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">TATA box-binding protein</td>
                <td headers="hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/607136">607136</ext-link>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Benign hereditary chorea (BHC)</td>
                <td headers="hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">TITF-1</italic>
                </td>
                <td headers="hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">14q-13.1</td>
                <td headers="hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Thyroid transcription factor 1</td>
                <td headers="hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/118700">118700</ext-link>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_1 hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_2 hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_3 hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_4 hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_5" valign="middle" colspan="5" align="left" scope="col" rowspan="1">
                  <bold>Autosomal Recessive</bold>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <related-object link-type="booklink" source-id="gene" document-id="chac" document-type="chapter">Chorea-acanthocytosis</related-object>
                </td>
                <td headers="hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">VPS13A</italic>
                </td>
                <td headers="hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">9q21</td>
                <td headers="hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Chorein</td>
                <td headers="hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/200150">200150</ext-link>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">HDL3 (Huntington disease-like 3)</td>
                <td headers="hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">HDL3</italic>
                </td>
                <td headers="hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">4p15.3</td>
                <td headers="hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Protein not identified</td>
                <td headers="hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/604802">604802</ext-link>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <related-object link-type="booklink" source-id="gene" document-id="wilson" document-type="chapter">Wilson disease</related-object>
                </td>
                <td headers="hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">ATP7B</italic>
                </td>
                <td headers="hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">13q14.3-q21.1</td>
                <td headers="hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Copper transporting ATPase 2</td>
                <td headers="hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/277900">277900</ext-link>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <related-object link-type="booklink" source-id="gene" document-id="acp" document-type="chapter">Aceruloplasminemia</related-object>
                </td>
                <td headers="hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">CP</italic>
                </td>
                <td headers="hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">3q23-q24</td>
                <td headers="hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Ceruloplasmin</td>
                <td headers="hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/604290">604290</ext-link>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1"><related-object link-type="booklink" source-id="gene" document-id="pkan" document-type="chapter">Pantothenate kinase-associated neurodegeneration</related-object>, including HARP</td>
                <td headers="hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">PANK2</italic>
                </td>
                <td headers="hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">20p13-p12.3</td>
                <td headers="hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Pantothenate kinase 2</td>
                <td headers="hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/234200">234200</ext-link>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1"><related-object link-type="booklink" source-id="gene" document-id="inad" document-type="chapter"><italic toggle="yes">PLA2G6</italic>-associated neurodegeneration</related-object> (PLAN) (infantile neuroaxonal dystrophy; Karak syndrome)</td>
                <td headers="hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">PLA2G6</italic>
                </td>
                <td headers="hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">2q13.1</td>
                <td headers="hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">85-kd calcium-independent phospholipase A2</td>
                <td headers="hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/256600">256600</ext-link> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/610217">610217</ext-link>)</td>
              </tr>
              <tr>
                <td headers="hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_1 hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_2 hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_3 hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_4 hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_5" valign="middle" colspan="5" align="left" scope="col" rowspan="1">
                  <bold>X-Linked</bold>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1"><related-object link-type="booklink" source-id="gene" document-id="xdp" document-type="chapter">X-linked dystonia-parkinsonism syndrome</related-object> (Lubag)</td>
                <td headers="hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">DYT3</italic>
                </td>
                <td headers="hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Xq13.1</td>
                <td headers="hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Multiple transcript system DYT3</td>
                <td headers="hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/314250">314250</ext-link>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <related-object link-type="booklink" source-id="gene" document-id="lns" document-type="chapter">Lesch-Nyhan syndrome</related-object>
                </td>
                <td headers="hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">HPRT1</italic>
                </td>
                <td headers="hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Xq26-q27.2</td>
                <td headers="hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Hypoxanthine guanine phosphoribosyl-transferase 1</td>
                <td headers="hd_h_mcleod.T.differential_diagnosis_of_mcleo_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/300322">300322</ext-link>
                </td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
      </sec>
      <sec id="mcleod.Management_1">
        <title>Management</title>
        <sec id="mcleod.Evaluations_Following_Initial_Dia">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease in an individual diagnosed with McLeod neuroacanthocytosis syndrome (MLS), the following evaluations are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Neurologic and neuropsychological examination</p>
            </list-item>
            <list-item>
              <p>Serum CK concentration and liver function tests</p>
            </list-item>
            <list-item>
              <p>Cardiac examination, including ECG, Holter ECG, and echocardiography</p>
            </list-item>
            <list-item>
              <p>Cerebral MRI and electroencephalography</p>
            </list-item>
            <list-item>
              <p>Medical genetics consultation</p>
            </list-item>
          </list>
        </sec>
        <sec id="mcleod.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>The following are indicated:</p>
          <list list-type="bullet">
            <list-item>
              <p>Dopamine antagonists including tiapride, clozapine, or quetiapine, as well as dopamine depletor tetrabenazine to ameliorate chorea</p>
            </list-item>
            <list-item>
              <p>Treatment of psychiatric problems according to the clinical presentation</p>
            </list-item>
            <list-item>
              <p>Treatment of cardiac abnormalities according to the clinical and/or ECG presentation</p>
            </list-item>
            <list-item>
              <p>Antiepileptic drugs (AEDs) for treatment of seizures</p>
            </list-item>
            <list-item>
              <p>Extended and continuous multidisciplinary psychosocial support for affected individuals and their families</p>
            </list-item>
          </list>
        </sec>
        <sec id="mcleod.Prevention_of_Secondary_Complicat">
          <title>Prevention of Secondary Complications</title>
          <p>Transfusion hazards secondary to anti-Kx antibody production resulting from previous exposure to Kx antigens during homologous blood transfusion must be considered in:</p>
          <list list-type="bullet">
            <list-item>
              <p>All males with the McLeod blood group phenotype [<xref ref-type="bibr" rid="mcleod.REF.russo.2000b.1371">Russo et al 2000b</xref>], in particular males with X-linked <related-object link-type="booklink" source-id="gene" document-id="cgd" document-type="chapter">chronic granulomatous disease</related-object> resulting from a contiguous gene deletion of <italic toggle="yes">CYBB</italic> and <italic toggle="yes">XK</italic> (see Diagnosis, <xref ref-type="sec" rid="mcleod.Contiguous_Gene_Rearrangements">Contiguous Gene Rearrangements</xref>) [<xref ref-type="bibr" rid="mcleod.REF.holland.2005.1677">Holland 2005</xref>]; and</p>
            </list-item>
            <list-item>
              <p>Carrier females with the McLeod blood group phenotype.</p>
            </list-item>
          </list>
          <p>Kx-negative blood or, if possible, banked autologous blood should be used for transfusions.</p>
        </sec>
        <sec id="mcleod.Surveillance">
          <title>Surveillance</title>
          <p>Early recognition and treatment of cardiac problems and seizures is important, as these potential complications may be severe and appear to cause premature death [<xref ref-type="bibr" rid="mcleod.REF.danek.2001a.755">Danek et al 2001a</xref>].</p>
          <list list-type="bullet">
            <list-item>
              <p>If no pathologic findings are identified at initial evaluation, cardiac examinations (Holter ECG and echocardiography) should be repeated every two to three years.</p>
            </list-item>
            <list-item>
              <p>In the case of suspected epilepsy, EEG should be performed. If AED treatment is indicated, medication-specific laboratory parameters and serum concentrations should be followed.</p>
            </list-item>
          </list>
          <p>One individual with MLS developed life-threatening rhabdomyolysis; thus, serum CK concentrations should be carefully monitored, in particular if excessive movement disorders are present or if neuroleptic medications are being used [<xref ref-type="bibr" rid="mcleod.REF.jung.2002.424">Jung &#x00026; Brandner 2002</xref>].</p>
        </sec>
        <sec id="mcleod.AgentsCircumstances_to_Avoid">
          <title>Agents/Circumstances to Avoid</title>
          <p>Blood transfusions with Kx antigens should be avoided in males and females with the McLeod blood group phenotype. Kx-negative blood or, if possible, banked autologous blood should be used for transfusions.</p>
          <p>Treatment with neuroleptics, in particular clozapine, should be carefully monitored.</p>
        </sec>
        <sec id="mcleod.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>See <xref ref-type="sec" rid="mcleod.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="mcleod.Pregnancy_Management">
          <title>Pregnancy Management</title>
          <p>In female heterozygotes, the probability of manifestations of the McLeod neuroacanthocytosis syndrome in the reproductive period is presumably very low; thus, no particular recommendations can be made. Of note, transfusion reactions have to be considered in female carriers who have the McLeod blood group phenotype (see <xref ref-type="sec" rid="mcleod.Prevention_of_Secondary_Complicat">Prevention of Secondary Complications</xref>).</p>
          <p>No prenatal or perinatal neurologic manifestations of MLS are known; however, severe anemia can be observed in Kell-positive newborns born to sensitized Kell-negative mothers [<xref ref-type="bibr" rid="mcleod.REF.lee.2000b.113">Lee et al 2000b</xref>, <xref ref-type="bibr" rid="mcleod.REF.jung.2007.112">Jung et al 2007</xref>].</p>
        </sec>
        <sec id="mcleod.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p>
        </sec>
      </sec>
      <sec id="mcleod.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="mcleod.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>McLeod neuroacanthocytosis syndrome (MLS) is inherited in an X-linked manner.</p>
        </sec>
        <sec id="mcleod.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of the proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The father of an affected male will not have the disease nor will he be a carrier of the pathogenic variant.</p>
            </list-item>
            <list-item>
              <p>In a family with more than one affected individual, the mother of an affected male is an obligate carrier.</p>
            </list-item>
            <list-item>
              <p>If pedigree analysis reveals that the proband is the only affected family member, the mother may be a carrier or the affected male may have a <italic toggle="yes">de novo</italic> pathogenic variant, in which case the mother is not a carrier. One <italic toggle="yes">de novo</italic>
<italic toggle="yes">XK</italic> pathogenic variant has been described in MLS [<xref ref-type="bibr" rid="mcleod.REF.supple.2001.369">Supple et al 2001</xref>].</p>
            </list-item>
            <list-item>
              <p>If a woman has more than one affected son and the pathogenic variant cannot be detected in DNA extracted from her leukocytes, she may have germline mosaicism. No data regarding germline mosaicism in MLS are available to date.</p>
            </list-item>
            <list-item>
              <p>Females heterozygous for <italic toggle="yes">XK</italic> pathogenic variants have mosaicism for the Kell and Kx blood group antigens but usually lack CNS and neuromuscular manifestations. However, some heterozygous females may develop clinical manifestations including chorea or late-onset cognitive decline.</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of the proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to sibs depends on the carrier status of the mother.</p>
            </list-item>
            <list-item>
              <p>If the mother of the proband has a pathogenic variant, the chance of transmitting it in each pregnancy is 50%. Males who inherit the variant will be affected; females who inherit the variant will be carriers and will usually not be affected.</p>
            </list-item>
            <list-item>
              <p>Females heterozygous for <italic toggle="yes">XK</italic> pathogenic variants have mosaicism for the Kell and Kx blood group antigens but usually lack CNS and neuromuscular manifestations. However, some heterozygous females may develop clinical manifestations including chorea or late-onset cognitive decline.</p>
            </list-item>
            <list-item>
              <p>If the pathogenic variant has not been identified in the mother's DNA, the risk to sibs is low but greater than that of the general population because of the possibility of germline mosaicism.</p>
            </list-item>
          </list>
          <p><bold>Offspring of the proband.</bold> Affected males will pass the pathogenic variant to all of their daughters and none of their sons.</p>
          <p><bold>Other family members of the proband.</bold> The proband's maternal aunts may be at risk of being carriers and the aunt's offspring, depending on their gender, may be at risk of being carriers or of being affected.</p>
        </sec>
        <sec id="mcleod.Carrier_Detection">
          <title>Carrier Detection</title>
          <p>If the pathogenic variant in the family have been identified, carrier testing for at-risk family members may be available from a laboratory offering either testing of the gene of interest or custom testing. Carrier testing using immunohematologic techniques is possible.</p>
        </sec>
        <sec id="mcleod.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk, clarification of carrier status, and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected, are carriers, or are at risk of being carriers.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="mcleod.Prenatal_Testing">
          <title>Prenatal Testing</title>
          <p>If the pathogenic variant has been identified in an affected family member, prenatal testing for at-risk pregnancies may be available from a laboratory offering either testing for the gene of interest or custom prenatal testing.</p>
          <p><bold>Preimplantation genetic diagnosis (PGD)</bold> may be an option for some families in which the pathogenic variant has been identified.</p>
        </sec>
      </sec>
      <sec id="mcleod.Resources">
        <title>Resources</title>
      </sec>
      <sec id="mcleod.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <p>Note: The terms "Kell blood group precursor" for the XK protein or the Kx RBC antigen, respectively, are incorrect and should no longer be used.</p>
        <sec id="mcleod.Molecular_Genetic_Pathogenesis">
          <title>Molecular Genetic Pathogenesis</title>
          <p>The XK protein is predicted to have ten transmembrane domains and the structural characteristics of prokaryotic and eukaryotic membrane transport proteins [<xref ref-type="bibr" rid="mcleod.REF.ho.1994.869">Ho et al 1994</xref>]. The XK protein is linked to the Kell glycoprotein by a single disulfide bond (XK Cys<sup>347</sup>- Kell Cys<sup>72</sup>) when they are co-expressed, and the two proteins most probably form a functional complex [<xref ref-type="bibr" rid="mcleod.REF.russo.1998.13950">Russo et al 1998</xref>]. XK and Kell are predominantly expressed in erythroid tissues, but their expression in non-erythroid tissues differs. XK is ubiquitously expressed in many other tissues, especially in high amounts in skeletal muscle and brain. In contrast, Kell is expressed in very small amounts in different tissues including human brain and skeletal muscle. XK and Kell are both expressed in testis [<xref ref-type="bibr" rid="mcleod.REF.russo.2000a.340">Russo et al 2000a</xref>, <xref ref-type="bibr" rid="mcleod.REF.camaraclayette.2001.171">Camara-Clayette et al 2001</xref>, <xref ref-type="bibr" rid="mcleod.REF.jung.2001b.1346">Jung et al 2001b</xref>]. However, recent studies by in situ hybridization histochemistry (ISHH) and RT-PCR of mouse tissues indicate that Kell is not present in brain and skeletal muscle in that species. XK is expressed in various cerebral regions, with high amounts in pontine region, olfactory lobe, and cerebellum [<xref ref-type="bibr" rid="mcleod.REF.lee.2007.365">Lee et al 2007</xref>].</p>
          <p>It has been proposed that the function of isolated XK differs from that of XK in combination with Kell. The Kell protein (product of <italic toggle="yes">KEL</italic> on chromosome 7) is a member of M13 family of zinc endopeptidases and is an endothelin-3 converting enzyme generating the bioactive endothelin-3 [<xref ref-type="bibr" rid="mcleod.REF.lee.1999.1440">Lee et al 1999</xref>, <xref ref-type="bibr" rid="mcleod.REF.lee.2000b.113">Lee et al 2000b</xref>]. Experimental studies have demonstrated that endothelin is a neurotrophic factor at low concentrations and a cytotoxic factor at high concentrations, suggesting that endothelin-related mechanisms could be implicated in neurodegeneration [<xref ref-type="bibr" rid="mcleod.REF.ehrenreich.2000.993">Ehrenreich et al 2000</xref>]. However, no acanthocytosis or cerebral or neuromuscular signs and symptoms have been described in individuals with absent Kell membrane glycoproteins caused by the so-called <italic toggle="yes">KEL</italic> null (K<sub>0</sub>)-phenotype [<xref ref-type="bibr" rid="mcleod.REF.lee.2000a.93">Lee et al 2000a</xref>; <xref ref-type="bibr" rid="mcleod.REF.k_rm_czi.2007.703">K&#x000f6;rm&#x000f6;czi et al 2007</xref>].</p>
          <p><bold>XK dysfunction may cause apoptosis</bold> dysregulation, which should be considered a major cause of myopathy and striatal neurodegeneration in McLeod neuroacanthocytosis syndrome. The XK protein is a member of XK family that comprises XK, XPLAC, and XTES. Phylogenetic analysis has shown that XK and XPLAC are present in vertebrate fish while XTES is found only in primate testis [<xref ref-type="bibr" rid="mcleod.REF.calenda.2006.6">Calenda et al 2006</xref>]. In addition to the XK family, the phylogram contained five gene clusters distantly related to the XK and ced-8 gene clusters that are present in the nematode <italic toggle="yes">C. elegans</italic>. The ced-8 domain (FLxxxPQL[x]<sub>n</sub>WxxxxxxxR[x]<sub>n</sub>HP) is a typical signature sequence found in all members of the XK-related gene clusters. The ced-8 protein of <italic toggle="yes">C. elegans</italic> shares a low homology with XK protein but the topologic structure is similar to XK. The ced-8 protein is reported to play a role as a cell death effector downstream of the caspase ced-3 [<xref ref-type="bibr" rid="mcleod.REF.stanfield.2000.423">Stanfield &#x00026; Horvitz 2000</xref>]. The human homologue of ced-3, caspase-8, plays a crucial role in the striatal neurodegeneration of <related-object link-type="booklink" source-id="gene" document-id="huntington" document-type="chapter">Huntington disease</related-object> [<xref ref-type="bibr" rid="mcleod.REF.hackam.2000.41299">Hackam et al 2000</xref>, <xref ref-type="bibr" rid="mcleod.REF.gervais.2002.95">Gervais et al 2002</xref>].</p>
          <p><bold>Gene structure.</bold>
<italic toggle="yes">XK</italic> comprises three exons. Only one splicing variant is known [<xref ref-type="bibr" rid="mcleod.REF.walker.2007a.299">Walker et al 2007a</xref>]. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="mcleod" object-id="mcleod.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
          <p><bold>Pathogenic allelic variants.</bold> The vast majority of <italic toggle="yes">XK</italic> pathogenic variants are deletions, nonsense variants, or splice-site variants predicting absent or truncated Kx protein devoid of the Kell protein binding site [<xref ref-type="bibr" rid="mcleod.REF.ho.1994.869">Ho et al 1994</xref>, <xref ref-type="bibr" rid="mcleod.REF.ho.1996.672">Ho et al 1996</xref>, <xref ref-type="bibr" rid="mcleod.REF.hanaoka.1999.6">Hanaoka et al 1999</xref>, <xref ref-type="bibr" rid="mcleod.REF.dotti.2000.1282">Dotti et al 2000</xref>, <xref ref-type="bibr" rid="mcleod.REF.ueyama.2000.151">Ueyama et al 2000</xref>, <xref ref-type="bibr" rid="mcleod.REF.danek.2001a.755">Danek et al 2001a</xref>, <xref ref-type="bibr" rid="mcleod.REF.jung.2001a.384">Jung et al 2001a</xref>, <xref ref-type="bibr" rid="mcleod.REF.supple.2001.369">Supple et al 2001</xref>, <xref ref-type="bibr" rid="mcleod.REF.russo.2002.287">Russo et al 2002</xref>, <xref ref-type="bibr" rid="mcleod.REF.jung.2003.928">Jung et al 2003</xref>, <xref ref-type="bibr" rid="mcleod.REF.singleton.2003.682">Singleton et al 2003</xref>].</p>
          <p><inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="mcleod-Table3.pdf" content-type="local-data">Table 3</inline-supplementary-material> (pdf) summarizes the pathogenic variants identified in <italic toggle="yes">XK</italic>. See also <related-object source-id="gene" document-id="mcleod" object-id="mcleod.molgen.TA">Table A</related-object>, <xref ref-type="bibr" rid="mcleod.REF.walker.2007a.299">Walker et al [2007a]</xref>.</p>
          <p>Only three <italic toggle="yes">XK</italic> pathogenic missense variants have been reported to date (<xref ref-type="table" rid="mcleod.T.selected_xk_pathogenic_variants">Table 4</xref>). Although rare, they are potentially useful in the elucidation of structural and functional relationships (see <bold>Normal gene product</bold>).</p>
          <table-wrap id="mcleod.T.selected_xk_pathogenic_variants" position="anchor" orientation="portrait">
            <label>Table 4. </label>
            <caption>
              <p>Selected <italic toggle="yes">XK</italic> Pathogenic Variants</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_mcleod.T.selected_xk_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change <break/>(Alias&#x000a0;<sup>1</sup>)</th>
                  <th id="hd_h_mcleod.T.selected_xk_pathogenic_variants_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Protein Amino Acid Change</th>
                  <th id="hd_h_mcleod.T.selected_xk_pathogenic_variants_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_mcleod.T.selected_xk_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.508+5G&#x0003e;A</td>
                  <td headers="hd_h_mcleod.T.selected_xk_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">--</td>
                  <td headers="hd_h_mcleod.T.selected_xk_pathogenic_variants_1_1_1_3" rowspan="4" valign="middle" align="left" colspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_021083.2">NM_021083.2</ext-link>
<break/><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_066569.1">NP_066569.1</ext-link></td>
                </tr>
                <tr>
                  <td headers="hd_h_mcleod.T.selected_xk_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.664C&#x0003e;G<break/>(746C&#x0003e;G)</td>
                  <td headers="hd_h_mcleod.T.selected_xk_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg222Gly</td>
                </tr>
                <tr>
                  <td headers="hd_h_mcleod.T.selected_xk_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.880T&#x0003e;C<break/>(962T&#x0003e;C)</td>
                  <td headers="hd_h_mcleod.T.selected_xk_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Cys294Arg</td>
                </tr>
                <tr>
                  <td headers="hd_h_mcleod.T.selected_xk_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.979G&#x0003e;A<break/>(1061G&#x0003e;A)</td>
                  <td headers="hd_h_mcleod.T.selected_xk_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Glu327Lys</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn>
                <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
              </fn>
              <fn>
                <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
              </fn>
              <fn id="mcleod.TF.4.1">
                <label>1. </label>
                <p>Variant designation that does not conform to current naming conventions</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p><bold>Normal gene product.</bold> XK is a 444-amino acid protein. The exact function of the XK protein is not known, but its predicted structure suggests that it is a membrane transport protein [<xref ref-type="bibr" rid="mcleod.REF.ho.1994.869">Ho et al 1994</xref>].</p>
          <p>All three of the pathogenic missense variants occurred in the transmembrane domains and on highly conserved amino-acid residues that are evolutionarily related to XK, suggesting possible important roles in structure or function. The Glu327 and Arg222 residues may be involved in the basic structure of XK rather than in its function, and the Cys294 residue, which is conserved specifically in the <italic toggle="yes">XK</italic> family, may be critical for normal function [<xref ref-type="bibr" rid="mcleod.REF.walker.2007a.299">Walker et al 2007a</xref>].</p>
          <p><bold>Abnormal gene product.</bold> Most <italic toggle="yes">XK</italic> pathogenic variants predict an absent or truncated XK protein devoid of the Kell protein-binding site, suggesting a loss of function. For missense variants, see <bold>Normal gene product</bold>.</p>
        </sec>
      </sec>
      <sec id="mcleod.References">
        <title>References</title>
        <sec id="mcleod.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="mcleod.Literature_Cited.reflist0">
            <ref id="mcleod.REF.allen.1961.555">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Allen</surname>
                    <given-names>FH</given-names>
                    <suffix>Jr</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Krabbe</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Corcoran</surname>
                    <given-names>PA</given-names>
                  </name>
                </person-group>
                <year>1961</year>
                <article-title>A new phenotype (McLeod) in the Kell blood-group system.</article-title>
                <source>Vox Sang</source>
                <volume>6</volume>
                <fpage>555</fpage>
                <lpage>60</lpage>
                <pub-id pub-id-type="pmid">13860532</pub-id>
              </element-citation>
            </ref>
            <ref id="mcleod.REF.bertelson.1988.703">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bertelson</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pogo</surname>
                    <given-names>AO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chaudhuri</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marsh</surname>
                    <given-names>WL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Redman</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Banerjee</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Symmans</surname>
                    <given-names>WA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Simon</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frey</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kunkel</surname>
                    <given-names>LM</given-names>
                  </name>
                </person-group>
                <year>1988</year>
                <article-title>Localization of the McLeod locus (XK) within Xp21 by deletion analysis.</article-title>
                <source>Am J Hum Genet</source>
                <volume>42</volume>
                <fpage>703</fpage>
                <lpage>11</lpage>
                <pub-id pub-id-type="pmid">3358422</pub-id>
              </element-citation>
            </ref>
            <ref id="mcleod.REF.calenda.2006.6">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Calenda</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peng</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Redman</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sha</surname>
                    <given-names>Q</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Identification of two new members, XPLAC and XTES, of the XK family.</article-title>
                <source>Gene</source>
                <volume>370</volume>
                <fpage>6</fpage>
                <lpage>16</lpage>
                <pub-id pub-id-type="pmid">16431037</pub-id>
              </element-citation>
            </ref>
            <ref id="mcleod.REF.camaraclayette.2001.171">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Camara-Clayette</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rahuel</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lopez</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hattab</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Verkarre</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertrand</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cartron</surname>
                    <given-names>JP</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Transcriptional regulation of the KEL gene and Kell protein expression in erythroid and non-erythroid cells.</article-title>
                <source>Biochem J</source>
                <volume>356</volume>
                <fpage>171</fpage>
                <lpage>80</lpage>
                <pub-id pub-id-type="pmid">11336649</pub-id>
              </element-citation>
            </ref>
            <ref id="mcleod.REF.chauveau.2011.1562">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chauveau</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Damon-Perriere</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jung</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Latxague</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spampinato</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burbaud</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tison</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Head drops are also observed in the McLeod syndrome.</article-title>
                <source>Mov Disord</source>
                <volume>26</volume>
                <fpage>1562</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">21469202</pub-id>
              </element-citation>
            </ref>
            <ref id="mcleod.REF.ching.2002.1673">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ching</surname>
                    <given-names>KH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Westaway</surname>
                    <given-names>SK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gitschier</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Higgins</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hayflick</surname>
                    <given-names>SJ</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>HARP syndrome is allelic with pantothenate kinase-associated neurodegeneration.</article-title>
                <source>Neurology</source>
                <volume>58</volume>
                <fpage>1673</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">12058097</pub-id>
              </element-citation>
            </ref>
            <ref id="mcleod.REF.danek.2005.171">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Danek</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jung</surname>
                    <given-names>HH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Melone</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rampoldi</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Broccoli</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walker</surname>
                    <given-names>RH</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Neuroacanthocytosis: new developments in a neglected group of dementing disorders.</article-title>
                <source>J Neurol Sci</source>
                <volume>229-230</volume>
                <fpage>171</fpage>
                <lpage>86</lpage>
                <pub-id pub-id-type="pmid">15760637</pub-id>
              </element-citation>
            </ref>
            <ref id="mcleod.REF.danek.2008">
              <mixed-citation publication-type="book">Danek A, Neumann M, Brin MF, Symmans WA, Hays AP. Cerebral involvement in McLeod syndrome: the first autopsy revisited. In: Walker RH, Saiki S, Danek A, eds. <italic toggle="yes">Neuroacanthocytosis Syndromes II.</italic> Heidelberg, Germany: Springer; 2008:205-15.</mixed-citation>
            </ref>
            <ref id="mcleod.REF.danek.2001a.755">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Danek</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rubio</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rampoldi</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ho</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dobson-Stone</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tison</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Symmans</surname>
                    <given-names>WA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oechsner</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kalckreuth</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Watt</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Corbett</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamdalla</surname>
                    <given-names>HH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marshall</surname>
                    <given-names>AG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sutton</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dotti</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malandrini</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walker</surname>
                    <given-names>RH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Daniels</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Monaco</surname>
                    <given-names>AP</given-names>
                  </name>
                </person-group>
                <year>2001a</year>
                <article-title>McLeod neuroacanthocytosis: genotype and phenotype.</article-title>
                <source>Ann Neurol</source>
                <volume>50</volume>
                <fpage>755</fpage>
                <lpage>64</lpage>
                <pub-id pub-id-type="pmid">11761473</pub-id>
              </element-citation>
            </ref>
            <ref id="mcleod.REF.danek.2004">
              <mixed-citation publication-type="book">Danek A, Sheesley L, Tierney M, Uttner I, Grafman J. Cognitive and neuropsychiatric findings in McLeod syndrome and in chorea-acanthocytosis. In: Danek A, ed. <italic toggle="yes">Neuroacanthocytosis Syndromes</italic>. Dordrecht, Netherlands: Springer; 2004:95-115.</mixed-citation>
            </ref>
            <ref id="mcleod.REF.danek.2001b.882">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Danek</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tison</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rubio</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oechsner</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kalckreuth</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Monaco</surname>
                    <given-names>AP</given-names>
                  </name>
                </person-group>
                <year>2001b</year>
                <article-title>The chorea of McLeod syndrome.</article-title>
                <source>Mov Disord</source>
                <volume>16</volume>
                <fpage>882</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">11746618</pub-id>
              </element-citation>
            </ref>
            <ref id="mcleod.REF.danek.1994.117">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Danek</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uttner</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vogl</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tatsch</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Witt</surname>
                    <given-names>TN</given-names>
                  </name>
                </person-group>
                <year>1994</year>
                <article-title>Cerebral involvement in McLeod syndrome.</article-title>
                <source>Neurology</source>
                <volume>44</volume>
                <fpage>117</fpage>
                <lpage>20</lpage>
                <pub-id pub-id-type="pmid">8290045</pub-id>
              </element-citation>
            </ref>
            <ref id="mcleod.REF.dobsonstone.2004.299">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dobson-Stone</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Velayos-Baeza</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Filippone</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Westbury</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Storch</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Erdmann</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wroe</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leenders</surname>
                    <given-names>KL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lang</surname>
                    <given-names>AE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dotti</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Federico</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mohiddin</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fananapazir</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Daniels</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Danek</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Monaco</surname>
                    <given-names>AP</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Chorein detection for the diagnosis of chorea-acanthocytosis.</article-title>
                <source>Ann Neurol</source>
                <volume>56</volume>
                <fpage>299</fpage>
                <lpage>302</lpage>
                <pub-id pub-id-type="pmid">15293285</pub-id>
              </element-citation>
            </ref>
            <ref id="mcleod.REF.dotti.2000.1282">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dotti</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Battisti</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malandrini</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Federico</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rubio</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Circiarello</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Monaco</surname>
                    <given-names>AP</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>McLeod syndrome and neuroacanthocytosis with a novel mutation in the XK gene.</article-title>
                <source>Mov Disord</source>
                <volume>15</volume>
                <fpage>1282</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">11104227</pub-id>
              </element-citation>
            </ref>
            <ref id="mcleod.REF.dotti.2004">
              <mixed-citation publication-type="book">Dotti MT, Malandrini A, Federico A. Neuromuscular findings in eight Italian families with neuroacanthocytosis. In: Danek A, ed. <italic toggle="yes">Neuroacanthocytosis Syndromes</italic>. Dordrecht, Netherlands: Springer; 2004:127-38.</mixed-citation>
            </ref>
            <ref id="mcleod.REF.dydak.2006.17">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dydak</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mueller</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sandor</surname>
                    <given-names>PS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meier</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boesiger</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jung</surname>
                    <given-names>HH</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Cerebral metabolic alterations in McLeod syndrome.</article-title>
                <source>Eur Neurol</source>
                <volume>56</volume>
                <fpage>17</fpage>
                <lpage>23</lpage>
                <pub-id pub-id-type="pmid">16914926</pub-id>
              </element-citation>
            </ref>
            <ref id="mcleod.REF.ehrenreich.2000.993">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ehrenreich</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nau</surname>
                    <given-names>TR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dembowski</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hasselblatt</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barth</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hahn</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schilling</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Siren</surname>
                    <given-names>A-L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bruck</surname>
                    <given-names>W</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Endothelin b receptor deficiency is associated with an increased rate of neuronal apoptosis in the dentate gyrus.</article-title>
                <source>Neuroscience</source>
                <volume>95</volume>
                <fpage>993</fpage>
                <lpage>1001</lpage>
                <pub-id pub-id-type="pmid">10682706</pub-id>
              </element-citation>
            </ref>
            <ref id="mcleod.REF.gantenbein.2011.2123">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gantenbein</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Damon-Perri&#x000e8;re</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bohlender</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chauveau</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Latxague</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miranda</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jung</surname>
                    <given-names>HH.</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tison</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Feeding dystonia in McLeod syndrome.</article-title>
                <source>Mov Disord</source>
                <volume>26</volume>
                <fpage>2123</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">21714011</pub-id>
              </element-citation>
            </ref>
            <ref id="mcleod.REF.gervais.2002.95">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gervais</surname>
                    <given-names>FG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Singaraja</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xanthoudakis</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gutekunst</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leavitt</surname>
                    <given-names>BR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Metzler</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hackam</surname>
                    <given-names>AS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tam</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vaillancourt</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Houtzager</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rasper</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roy</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hayden</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nicholson</surname>
                    <given-names>DW</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Recruitment and activation of caspase-8 by the Huntingtin-interacting protein Hip-1 and a novel partner Hippi.</article-title>
                <source>Nat Cell Biol</source>
                <volume>4</volume>
                <fpage>95</fpage>
                <lpage>105</lpage>
                <pub-id pub-id-type="pmid">11788820</pub-id>
              </element-citation>
            </ref>
            <ref id="mcleod.REF.geser.2008">
              <mixed-citation publication-type="book">Geser F, Tolnay M, Jung HH. The neuropathology of McLeod syndrome. In: Walker RH, Saiki S, Danek A, eds. <italic toggle="yes">Neuroacanthocytosis Syndromes II.</italic> Heidelberg, Germany: Springer; 2008:197-203.</mixed-citation>
            </ref>
            <ref id="mcleod.REF.hackam.2000.41299">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hackam</surname>
                    <given-names>AS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yassa</surname>
                    <given-names>AS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Singaraja</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Metzler</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gutekunst</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gan</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Warby</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wellington</surname>
                    <given-names>CL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vaillancourt</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gervais</surname>
                    <given-names>FG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raymond</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nicholson</surname>
                    <given-names>DW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hayden</surname>
                    <given-names>MR</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Huntingtin interacting protein 1 induces apoptosis via a novel caspase-dependent death effector domain.</article-title>
                <source>J Biol Chem</source>
                <volume>275</volume>
                <fpage>41299</fpage>
                <lpage>308</lpage>
                <pub-id pub-id-type="pmid">11007801</pub-id>
              </element-citation>
            </ref>
            <ref id="mcleod.REF.hanaoka.1999.6">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hanaoka</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yoshida</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakamura</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Furihata</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seo</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tani</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takahashi</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ikeda</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hanyu</surname>
                    <given-names>N</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>A novel frameshift mutation in the McLeod syndrome gene in a Japanese family.</article-title>
                <source>J Neurol Sci</source>
                <volume>165</volume>
                <fpage>6</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">10426139</pub-id>
              </element-citation>
            </ref>
            <ref id="mcleod.REF.hardie.1991.13">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hardie</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pullon</surname>
                    <given-names>HW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harding</surname>
                    <given-names>AE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Owen</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pires</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Daniels</surname>
                    <given-names>GL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Imai</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Misra</surname>
                    <given-names>VP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>King</surname>
                    <given-names>RH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jacobs</surname>
                    <given-names>JM</given-names>
                  </name>
                  <etal/>
                </person-group>
                <year>1991</year>
                <article-title>Neuroacanthocytosis. A clinical, haematological and pathological study of 19 cases.</article-title>
                <source>Brain</source>
                <volume>114</volume>
                <fpage>13</fpage>
                <lpage>49</lpage>
                <pub-id pub-id-type="pmid">1998879</pub-id>
              </element-citation>
            </ref>
            <ref id="mcleod.REF.hayflick.2003.33">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hayflick</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Westaway</surname>
                    <given-names>SK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levinson</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhou</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johnson</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ching</surname>
                    <given-names>KH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gitschier</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome.</article-title>
                <source>N Engl J Med</source>
                <volume>348</volume>
                <fpage>33</fpage>
                <lpage>40</lpage>
                <pub-id pub-id-type="pmid">12510040</pub-id>
              </element-citation>
            </ref>
            <ref id="mcleod.REF.hewer.2007.3285">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hewer</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Danek</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schoser</surname>
                    <given-names>BG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miranda</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reichard</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Castiglioni</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oechsner</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goebel</surname>
                    <given-names>HH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heppner</surname>
                    <given-names>FL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jung</surname>
                    <given-names>HH</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>McLeod myopathy revisited &#x02013; more neurogenic and less benign.</article-title>
                <source>Brain</source>
                <volume>130</volume>
                <fpage>3285</fpage>
                <lpage>96</lpage>
                <pub-id pub-id-type="pmid">18055495</pub-id>
              </element-citation>
            </ref>
            <ref id="mcleod.REF.ho.1994.869">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ho</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chelly</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carter</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Danek</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crocker</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Monaco</surname>
                    <given-names>AP</given-names>
                  </name>
                </person-group>
                <year>1994</year>
                <article-title>Isolation of the gene for McLeod syndrome that encodes a novel membrane transport protein.</article-title>
                <source>Cell</source>
                <volume>77</volume>
                <fpage>869</fpage>
                <lpage>80</lpage>
                <pub-id pub-id-type="pmid">8004674</pub-id>
              </element-citation>
            </ref>
            <ref id="mcleod.REF.ho.1996.672">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ho</surname>
                    <given-names>MF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chalmers</surname>
                    <given-names>RM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davis</surname>
                    <given-names>MB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harding</surname>
                    <given-names>AE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Monaco</surname>
                    <given-names>AP</given-names>
                  </name>
                </person-group>
                <year>1996</year>
                <article-title>A novel point mutation in the McLeod syndrome gene in neuroacanthocytosis.</article-title>
                <source>Ann Neurol</source>
                <volume>39</volume>
                <fpage>672</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">8619554</pub-id>
              </element-citation>
            </ref>
            <ref id="mcleod.REF.holland.2005.1677">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Holland</surname>
                    <given-names>SM</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Chronic granulomatous disease and MLS.</article-title>
                <source>Mov Disord.</source>
                <volume>20</volume>
                <fpage>1677</fpage>
              </element-citation>
            </ref>
            <ref id="mcleod.REF.houlden.2003.1423">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Houlden</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lincoln</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farrer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cleland</surname>
                    <given-names>PG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hardy</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Orrell</surname>
                    <given-names>RW</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Compound heterozygous PANK2 mutations confirm HARP and Hallervorden-Spatz syndromes are allelic.</article-title>
                <source>Neurology</source>
                <volume>61</volume>
                <fpage>1423</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">14638969</pub-id>
              </element-citation>
            </ref>
            <ref id="mcleod.REF.ishikawa.2000.1113">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ishikawa</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tachibana</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tabata</surname>
                    <given-names>KI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fujimori</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hayashi</surname>
                    <given-names>RI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takahashi</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ikeda</surname>
                    <given-names>SI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hanyu</surname>
                    <given-names>N</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Muscle CT scan findings in McLeod syndrome and chorea-acanthocytosis.</article-title>
                <source>Muscle Nerve</source>
                <volume>23</volume>
                <fpage>1113</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">10883007</pub-id>
              </element-citation>
            </ref>
            <ref id="mcleod.REF.jung.2002.424">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jung</surname>
                    <given-names>HH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brandner</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Malignant McLeod myopathy.</article-title>
                <source>Muscle Nerve</source>
                <volume>26</volume>
                <fpage>424</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">12210375</pub-id>
              </element-citation>
            </ref>
            <ref id="mcleod.REF.jung.2007.112">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jung</surname>
                    <given-names>HH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Danek</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frey</surname>
                    <given-names>BM</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>McLeod Syndrome &#x02013; a neurohaematological disorder.</article-title>
                <source>Vox Sang</source>
                <volume>93</volume>
                <fpage>112</fpage>
                <lpage>21</lpage>
                <pub-id pub-id-type="pmid">17683354</pub-id>
              </element-citation>
            </ref>
            <ref id="mcleod.REF.jung.2011.68">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jung</surname>
                    <given-names>HH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Danek</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walker</surname>
                    <given-names>RH</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Neuroacanthocytosis syndromes.</article-title>
                <source>Orphanet J Rare Dis.</source>
                <volume>6</volume>
                <fpage>68</fpage>
                <pub-id pub-id-type="pmid">22027213</pub-id>
              </element-citation>
            </ref>
            <ref id="mcleod.REF.jung.2004.722">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jung</surname>
                    <given-names>HH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haker</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Schizophrenia as a manifestation of X-linked Mcleod-Neuroacanthocytosis syndrome.</article-title>
                <source>J Clin Psychiatry</source>
                <volume>65</volume>
                <fpage>722</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">15163264</pub-id>
              </element-citation>
            </ref>
            <ref id="mcleod.REF.jung.2001a.384">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jung</surname>
                    <given-names>HH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hergersberg</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kneifel</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alkadhi</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schiess</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weigell-Weber</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Daniels</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kollias</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hess</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>2001a</year>
                <article-title>McLeod syndrome: a novel mutation, predominant psychiatric manifestations, and distinct striatal imaging findings.</article-title>
                <source>Ann Neurol</source>
                <volume>49</volume>
                <fpage>384</fpage>
                <lpage>92</lpage>
                <pub-id pub-id-type="pmid">11261514</pub-id>
              </element-citation>
            </ref>
            <ref id="mcleod.REF.jung.2003.928">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jung</surname>
                    <given-names>HH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hergersberg</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vogt</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pahnke</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Treyer</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rothlisberger</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kollias</surname>
                    <given-names>SS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Russo</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frey</surname>
                    <given-names>BM</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>McLeod phenotype associated with a XK missense mutation without hematologic, neuromuscular, or cerebral involvement.</article-title>
                <source>Transfusion</source>
                <volume>43</volume>
                <fpage>928</fpage>
                <lpage>38</lpage>
                <pub-id pub-id-type="pmid">12823753</pub-id>
              </element-citation>
            </ref>
            <ref id="mcleod.REF.jung.2001b.1346">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jung</surname>
                    <given-names>HH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Russo</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Redman</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brandner</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2001b</year>
                <article-title>Kell and XK immunohistochemistry in McLeod myopathy.</article-title>
                <source>Muscle Nerve</source>
                <volume>24</volume>
                <fpage>1346</fpage>
                <lpage>51</lpage>
                <pub-id pub-id-type="pmid">11562915</pub-id>
              </element-citation>
            </ref>
            <ref id="mcleod.REF.kane.1995">
              <mixed-citation publication-type="book">Kane J, Havel RJ. Disorder of the biogenesis and secretion of lipoprotein containing the B apolipoproteins. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. <italic toggle="yes">The Metabolic and Molecular Bases of Inherited Disease</italic>. New York, NY: McGraw-Hill; 1995:1853-85.</mixed-citation>
            </ref>
            <ref id="mcleod.REF.kawakami.1999.36">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kawakami</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takiyama</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sakoe</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ogawa</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yoshioka</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishizawa</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reid</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kobayashi</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nonaka</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakano</surname>
                    <given-names>I</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>A case of McLeod syndrome with unusually severe myopathy.</article-title>
                <source>J Neurol Sci</source>
                <volume>166</volume>
                <fpage>36</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">10465497</pub-id>
              </element-citation>
            </ref>
            <ref id="mcleod.REF.k_rm_czi.2007.703">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>K&#x000f6;rm&#x000f6;czi</surname>
                    <given-names>GF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wagner</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jungbauer</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vadon</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ahrens</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moll</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000fc;hlebacher</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>&#x000d6;zg&#x000fc;l-G&#x000fc;lce</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kleinrath</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kilga-Nogler</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sch&#x000f6;nitzer</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gassner</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Genetic diversity of KELnull and KELel: a nationwide Austrian survey.</article-title>
                <source>Transfusion</source>
                <volume>47</volume>
                <fpage>703</fpage>
                <lpage>14</lpage>
                <pub-id pub-id-type="pmid">17381630</pub-id>
              </element-citation>
            </ref>
            <ref id="mcleod.REF.lee.1999.1440">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lin</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mele</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cao</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farmar</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Russo</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Redman</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Proteolytic processing of big endothelin-3 by the kell blood group protein.</article-title>
                <source>Blood</source>
                <volume>94</volume>
                <fpage>1440</fpage>
                <lpage>50</lpage>
                <pub-id pub-id-type="pmid">10438732</pub-id>
              </element-citation>
            </ref>
            <ref id="mcleod.REF.lee.2000a.93">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Russo</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Redman</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2000a</year>
                <article-title>Functional and structural aspects of the Kell blood group system.</article-title>
                <source>Transfus Med Rev</source>
                <volume>14</volume>
                <fpage>93</fpage>
                <lpage>103</lpage>
                <pub-id pub-id-type="pmid">10782495</pub-id>
              </element-citation>
            </ref>
            <ref id="mcleod.REF.lee.2000b.113">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Russo</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Redman</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2000b</year>
                <article-title>The Kell blood group system: Kell and XK membrane proteins.</article-title>
                <source>Semin Hematol</source>
                <volume>37</volume>
                <fpage>113</fpage>
                <lpage>21</lpage>
                <pub-id pub-id-type="pmid">10791880</pub-id>
              </element-citation>
            </ref>
            <ref id="mcleod.REF.lee.2007.365">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sha</surname>
                    <given-names>Q</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Calenda</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peng</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Expression profiles of mouse Kell, XK, and XPLAC mRNA.</article-title>
                <source>J Histochem Cytochem.</source>
                <volume>55</volume>
                <fpage>365</fpage>
                <lpage>74</lpage>
                <pub-id pub-id-type="pmid">17189525</pub-id>
              </element-citation>
            </ref>
            <ref id="mcleod.REF.margolis.2001.373">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Margolis</surname>
                    <given-names>RL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>O'Hearn</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosenblatt</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Willour</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holmes</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Franz</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Callahan</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hwang</surname>
                    <given-names>HS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Troncoso</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ross</surname>
                    <given-names>CA</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>A disorder similar to Huntington's disease is associated with a novel CAG repeat expansion.</article-title>
                <source>Ann Neurol.</source>
                <volume>50</volume>
                <issue>6</issue>
                <fpage>373</fpage>
                <lpage>80</lpage>
                <pub-id pub-id-type="pmid">11761463</pub-id>
              </element-citation>
            </ref>
            <ref id="mcleod.REF.mohiddin.2004">
              <mixed-citation publication-type="book">Mohiddin SA, Fananapazzir L. Cardiac involvement in the neuroacanthocytosis syndromes. In: Danek A, ed. <italic toggle="yes">Neuroacanthocytosis Syndromes</italic>. Dordrecht, Netherlands: Springer; 2004:139-52</mixed-citation>
            </ref>
            <ref id="mcleod.REF.nicholl.2004.1200">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nicholl</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sutton</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dotti</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Supple</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Danek</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lawden</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>White matter abnormalities on MRI in neuroacanthocytosis.</article-title>
                <source>J Neurol Neurosurg Psychiatry</source>
                <volume>75</volume>
                <fpage>1200</fpage>
                <lpage>1</lpage>
                <pub-id pub-id-type="pmid">15258233</pub-id>
              </element-citation>
            </ref>
            <ref id="mcleod.REF.oechslin.2009.130">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Oechslin</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaup</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jenni</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jung</surname>
                    <given-names>HH</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Cardiac abnormalities in McLeod syndrome.</article-title>
                <source>Int J Cardiol.</source>
                <volume>132</volume>
                <fpage>130</fpage>
                <lpage>2</lpage>
                <pub-id pub-id-type="pmid">18045706</pub-id>
              </element-citation>
            </ref>
            <ref id="mcleod.REF.oechsner.2001.517">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Oechsner</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buchert</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beyer</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Danek</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Reduction of striatal glucose metabolism in McLeod choreoacanthocytosis.</article-title>
                <source>J Neurol Neurosurg Psychiatry</source>
                <volume>70</volume>
                <fpage>517</fpage>
                <lpage>20</lpage>
                <pub-id pub-id-type="pmid">11254778</pub-id>
              </element-citation>
            </ref>
            <ref id="mcleod.REF.oyen.1996.160">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Oyen</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reid</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rubinstein</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ralph</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>1996</year>
                <article-title>A method to detect McLeod phenotype red blood cells.</article-title>
                <source>Immunohematology.</source>
                <volume>12</volume>
                <fpage>160</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">15387728</pub-id>
              </element-citation>
            </ref>
            <ref id="mcleod.REF.peng.2007.142">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Peng</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Redman</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Song</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walker</surname>
                    <given-names>RH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Westhoff</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Insights into extensive deletions around the XK locus associated with McLeod phenotype and characterization of two novel cases.</article-title>
                <source>Gene.</source>
                <volume>392</volume>
                <fpage>142</fpage>
                <lpage>50</lpage>
                <pub-id pub-id-type="pmid">17300882</pub-id>
              </element-citation>
            </ref>
            <ref id="mcleod.REF.russo.1998.13950">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Russo</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Redman</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Association of XK and Kell blood group proteins.</article-title>
                <source>J Biol Chem</source>
                <volume>273</volume>
                <fpage>13950</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">9593744</pub-id>
              </element-citation>
            </ref>
            <ref id="mcleod.REF.russo.2000a.340">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Russo</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Redman</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2000a</year>
                <article-title>Expression of Kell blood group protein in nonerythroid tissues.</article-title>
                <source>Blood</source>
                <volume>96</volume>
                <fpage>340</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">10891471</pub-id>
              </element-citation>
            </ref>
            <ref id="mcleod.REF.russo.2002.287">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Russo</surname>
                    <given-names>DC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reid</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Redman</surname>
                    <given-names>CM</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Point mutations causing the McLeod phenotype.</article-title>
                <source>Transfusion</source>
                <volume>42</volume>
                <fpage>287</fpage>
                <lpage>93</lpage>
                <pub-id pub-id-type="pmid">11961232</pub-id>
              </element-citation>
            </ref>
            <ref id="mcleod.REF.russo.2000b.1371">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Russo</surname>
                    <given-names>DC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oyen</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Powell</surname>
                    <given-names>VI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Perry</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hitchcock</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Redman</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reid</surname>
                    <given-names>ME</given-names>
                  </name>
                </person-group>
                <year>2000b</year>
                <article-title>First example of anti-Kx in a person with the McLeod phenotype and without chronic granulomatous disease.</article-title>
                <source>Transfusion</source>
                <volume>40</volume>
                <fpage>1371</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">11099667</pub-id>
              </element-citation>
            </ref>
            <ref id="mcleod.REF.singleton.2003.682">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Singleton</surname>
                    <given-names>BK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Green</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Renaud</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fuhr</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poole</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Daniels</surname>
                    <given-names>GL</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>McLeod syndrome resulting from a novel XK mutation.</article-title>
                <source>Br J Haematol</source>
                <volume>122</volume>
                <fpage>682</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">12899725</pub-id>
              </element-citation>
            </ref>
            <ref id="mcleod.REF.stanfield.2000.423">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Stanfield</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Horvitz</surname>
                    <given-names>HR</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>The ced-8 gene controls the timing of programmed cell deaths in C. elegans.</article-title>
                <source>Mol Cell</source>
                <volume>5</volume>
                <fpage>423</fpage>
                <lpage>33</lpage>
                <pub-id pub-id-type="pmid">10882128</pub-id>
              </element-citation>
            </ref>
            <ref id="mcleod.REF.stevanin.2002.965">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Stevanin</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Camuzat</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holmes</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Julien</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sahloul</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dode</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hahn-Barma</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ross</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Margolis</surname>
                    <given-names>RL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Durr</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brice</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>CAG/CTG repeat expansions at the Huntington's disease-like 2 locus are rare in Huntington's disease patients.</article-title>
                <source>Neurology</source>
                <volume>58</volume>
                <fpage>965</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">11914418</pub-id>
              </element-citation>
            </ref>
            <ref id="mcleod.REF.storch.2005.84">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Storch</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kornhass</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwarz</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Testing for acanthocytosis A prospective reader-blinded study in movement disorder patients.</article-title>
                <source>J Neurol</source>
                <volume>252</volume>
                <fpage>84</fpage>
                <lpage>90</lpage>
                <pub-id pub-id-type="pmid">15654559</pub-id>
              </element-citation>
            </ref>
            <ref id="mcleod.REF.supple.2001.369">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Supple</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iland</surname>
                    <given-names>HJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barnett</surname>
                    <given-names>MH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pollard</surname>
                    <given-names>JD</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>A spontaneous novel XK gene mutation in a patient with McLeod syndrome.</article-title>
                <source>Br J Haematol</source>
                <volume>115</volume>
                <fpage>369</fpage>
                <lpage>72</lpage>
                <pub-id pub-id-type="pmid">11703337</pub-id>
              </element-citation>
            </ref>
            <ref id="mcleod.REF.swaiman.2001.102">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Swaiman</surname>
                    <given-names>KF</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Hallervorden-Spatz syndrome.</article-title>
                <source>Pediatr Neurol</source>
                <volume>25</volume>
                <fpage>102</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">11551740</pub-id>
              </element-citation>
            </ref>
            <ref id="mcleod.REF.swash.1983.717">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Swash</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwartz</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carter</surname>
                    <given-names>ND</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heath</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leak</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rogers</surname>
                    <given-names>KL</given-names>
                  </name>
                </person-group>
                <year>1983</year>
                <article-title>Benign X-linked myopathy with acanthocytes (McLeod syndrome). Its relationship to X-linked muscular dystrophy.</article-title>
                <source>Brain</source>
                <volume>106</volume>
                <fpage>717</fpage>
                <lpage>33</lpage>
                <pub-id pub-id-type="pmid">6685553</pub-id>
              </element-citation>
            </ref>
            <ref id="mcleod.REF.symmans.1979.575">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Symmans</surname>
                    <given-names>WA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shepherd</surname>
                    <given-names>CS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marsh</surname>
                    <given-names>WL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oyen</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shohet</surname>
                    <given-names>SB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Linehan</surname>
                    <given-names>BJ</given-names>
                  </name>
                </person-group>
                <year>1979</year>
                <article-title>Hereditary acanthocytosis associated with the McLeod phenotype of the Kell blood group system.</article-title>
                <source>Br J Haematol</source>
                <volume>42</volume>
                <fpage>575</fpage>
                <lpage>83</lpage>
                <pub-id pub-id-type="pmid">476009</pub-id>
              </element-citation>
            </ref>
            <ref id="mcleod.REF.tarugi.2011.81">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tarugi</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Averna</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Hypobetalipoproteinemia: genetics, biochemistry, and clinical spectrum.</article-title>
                <source>Adv Clin Chem</source>
                <volume>54</volume>
                <fpage>81</fpage>
                <lpage>107</lpage>
                <pub-id pub-id-type="pmid">21874758</pub-id>
              </element-citation>
            </ref>
            <ref id="mcleod.REF.ueyama.2000.151">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ueyama</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kumamoto</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nagao</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Masuda</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sugihara</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fujimoto</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsuda</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>A novel mutation of the McLeod syndrome gene in a Japanese family.</article-title>
                <source>J Neurol Sci</source>
                <volume>176</volume>
                <fpage>151</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">10930599</pub-id>
              </element-citation>
            </ref>
            <ref id="mcleod.REF.valko.2010.612">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Valko</surname>
                    <given-names>PO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>H&#x000e4;nggi</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meyer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jung</surname>
                    <given-names>HH</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Evolution of striatal degeneration in McLeod syndrome.</article-title>
                <source>Eur J Neurol.</source>
                <volume>17</volume>
                <fpage>612</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">19968700</pub-id>
              </element-citation>
            </ref>
            <ref id="mcleod.REF.walker.2007a.299">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Walker</surname>
                    <given-names>RH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Danek</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uttner</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Offner</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reid</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2007a</year>
                <article-title>McLeod phenotype without the McLeod syndrome.</article-title>
                <source>Transfusion</source>
                <volume>47</volume>
                <fpage>299</fpage>
                <lpage>305</lpage>
                <pub-id pub-id-type="pmid">17302777</pub-id>
              </element-citation>
            </ref>
            <ref id="mcleod.REF.walker.2007b.244">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Walker</surname>
                    <given-names>RH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jung</surname>
                    <given-names>HH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tison</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Danek</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2007b</year>
                <article-title>Phenotypic variation among brothers with the McLeod neuroacanthocytosis syndrome.</article-title>
                <source>Mov Disord</source>
                <volume>22</volume>
                <fpage>244</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">17133513</pub-id>
              </element-citation>
            </ref>
            <ref id="mcleod.REF.walker.2003.1002">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Walker</surname>
                    <given-names>RH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rasmussen</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rudnicki</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holmes</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alonso</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matsuura</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ashizawa</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davidoff-Feldman</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Margolis</surname>
                    <given-names>RL</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Huntington's disease--like 2 can present as chorea-acanthocytosis.</article-title>
                <source>Neurology</source>
                <volume>61</volume>
                <fpage>1002</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">14557581</pub-id>
              </element-citation>
            </ref>
            <ref id="mcleod.REF.walterfang.2011.1275">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Walterfang</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Evans</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Looi</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jung</surname>
                    <given-names>HH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Danek</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walker</surname>
                    <given-names>RH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Velakoulis</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>The neuropsychiatry of neuroacanthocytosis syndromes.</article-title>
                <source>Neurosci Biobehav Rev.</source>
                <volume>35</volume>
                <fpage>1275</fpage>
                <lpage>83</lpage>
                <pub-id pub-id-type="pmid">21237198</pub-id>
              </element-citation>
            </ref>
            <ref id="mcleod.REF.witt.1992.302">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Witt</surname>
                    <given-names>TN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Danek</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reiter</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heim</surname>
                    <given-names>MU</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dirschinger</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Olsen</surname>
                    <given-names>EG</given-names>
                  </name>
                </person-group>
                <year>1992</year>
                <article-title>McLeod syndrome: a distinct form of neuroacanthocytosis. Report of two cases and literature review with emphasis on neuromuscular manifestations.</article-title>
                <source>J Neurol</source>
                <volume>239</volume>
                <fpage>302</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">1512605</pub-id>
              </element-citation>
            </ref>
            <ref id="mcleod.REF.zhou.2001.345">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zhou</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Westaway</surname>
                    <given-names>SK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levinson</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johnson</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gitschier</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hayflick</surname>
                    <given-names>SJ</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome.</article-title>
                <source>Nat Genet</source>
                <volume>28</volume>
                <fpage>345</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">11479594</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="mcleod.Suggested_Reading">
          <title>Suggested Reading</title>
          <ref-list id="mcleod.Suggested_Reading.reflist0">
            <ref id="mcleod.REF.danek.2004_1">
              <mixed-citation publication-type="book">Danek A, ed. <italic toggle="yes">Neuroacanthocytosis Syndromes</italic>. Dordrecht, Netherlands: Springer; 2004.</mixed-citation>
            </ref>
            <ref id="mcleod.REF.jung.2011.68_1">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jung</surname>
                    <given-names>HH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Danek</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walker</surname>
                    <given-names>RH</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Neuroacanthocytosis syndromes.</article-title>
                <source>Orphanet J Rare Dis.</source>
                <volume>6</volume>
                <fpage>68</fpage>
                <pub-id pub-id-type="pmid">22027213</pub-id>
              </element-citation>
            </ref>
            <ref id="mcleod.REF.prohaska.2012.607">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Prohaska</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sibon</surname>
                    <given-names>OC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rudnicki</surname>
                    <given-names>DD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Danek</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hayflick</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Verhaag</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vonk</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Margolis</surname>
                    <given-names>RL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walker</surname>
                    <given-names>RH</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Brain, blood, and iron: Perspectives on the roles of erythrocytes and iron in neurodegeneration.</article-title>
                <source>Neurobiol Dis.</source>
                <volume>46</volume>
                <fpage>607</fpage>
                <lpage>24</lpage>
                <pub-id pub-id-type="pmid">22426390</pub-id>
              </element-citation>
            </ref>
            <ref id="mcleod.REF.walker.2008">
              <mixed-citation publication-type="book">Walker RH, Saiki S, Danek A, eds. <italic toggle="yes">Neuroacanthocytosis Syndromes II.</italic> Berlin, Germany: Springer; 2008.</mixed-citation>
            </ref>
            <ref id="mcleod.REF.walker.2011.141">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Walker</surname>
                    <given-names>RH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jung</surname>
                    <given-names>HH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Danek</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Neuroacanthocytosis.</article-title>
                <source>Handb Clin Neurol.</source>
                <volume>100</volume>
                <fpage>141</fpage>
                <lpage>51</lpage>
                <pub-id pub-id-type="pmid">21496574</pub-id>
              </element-citation>
            </ref>
            <ref id="mcleod.REF.walker.2007.92">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Walker</surname>
                    <given-names>RH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jung</surname>
                    <given-names>HH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dobson-Stone</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rampoldi</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sano</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tison</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Danek</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Neurologic phenotypes associated with acanthocytosis.</article-title>
                <source>Neurology</source>
                <volume>68</volume>
                <fpage>92</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">17210889</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="mcleod.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="mcleod.Author_Notes">
          <title>Author Notes</title>
          <p>Hans H Jung is a leading senior consultant at the Department of Neurology, University Hospital Zurich, Switzerland where he runs consultations for neurogenetic and neuromuscular disorders. His research focuses on the clinical, pathologic, and molecular basis of chorea syndromes, in particular the McLeod neuroacanthocytosis syndrome.</p>
          <p>Adrian Danek, a professor of cognitive neurology at the University of Munich, has contributed to neuroacanthocytosis research since 1990. His interests also include functional brain anatomy, problem solving (Towers of Hanoi/London), the frontotemporal lobe degeneration syndromes (see <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ftld.de">www.ftld.de</ext-link>), and other familial dementias (see <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.dian-info.org/de">www.dian-info.org/de</ext-link>).</p>
          <p>Ruth H Walker is a movement disorders-trained neurologist whose research focuses on the functional neuroanatomy of the basal ganglia and clinicopathologic correlations of neurogenetic disorders. Her particular clinical interests are the hyperkinetic disorders, especially the rarer inherited causes of chorea.</p>
          <p>Beat M Frey is a board certified hematologist/oncologist/transfusion specialist running the Swiss Transfusion Service SRC in Schlieren/Z&#x000fc;rich, Switzerland. His research interests focus on functional and genetic aspects of blood group antigens and their implication for clinical practice.</p>
          <p>Christoph Gassner specializes in molecular blood group genotyping. In the context of McLeod, his research has primarily focused on establishing reliable genetic methods for the detection of pathogenic variants in <italic toggle="yes">XK</italic> and large X-chromosomal deletions. He is also interested in <italic toggle="yes">KEL</italic> genetics, with special focus on <italic toggle="yes">KEL</italic> null and other variants.</p>
        </sec>
        <sec id="mcleod.Acknowledgments">
          <title>Acknowledgments</title>
          <p>The authors thank The Advocacy for Neuroacanthocytosis Patients, in particular Glenn and Ginger Irvine, for their continuous support.</p>
        </sec>
        <sec id="mcleod.Author_History">
          <title>Author History</title>
          <p>Adrian Danek, MD (2004-present) Carol Dobson-Stone, DPhil; University of New South Wales (2004-2012) Beat M Frey, MD (2012-present)Christoph Gassner, PhD (2012-present)Hans H Jung, MD (2004-present) Sohee Lee, PhD; New York Blood Center (2007-2012) Colvin M Redman, PhD; New York Blood Center (2004-2007) Ruth H Walker, MD, MBBS, PhD (2012-present)</p>
        </sec>
        <sec id="mcleod.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>17 May 2012 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>26 March 2007 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>3 December 2004 (ca) Review posted to live Web site</p>
            </list-item>
            <list-item>
              <p>8 April 2004 (hj, ad) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
